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ABSTRACT
Different psychosocial factors influence the experience and adaptation to pain. Previous
cluster analytic studies using the Minnesota Multiphasic Personality Inventory-2nd edition
described psychologically different subgroups of pain patients that had been shown valuable in
determining outcome. However, these studies had limited applicability to medico-legal pain
populations because they did not use newly developed scales or describe important medico-legal
factors that have large effects on symptom endorsement. Using three methods of clustering, the
current investigation explored the subgroups that resulted when using all the MMPI-2 and the
newly developed MMPI-2-RF (Restructured Form) scales on a large and well-described
population of medico-legal spine pain patients. Result demonstrated that the best solution for the
current sample was the two-cluster solution when a traditional method was used. However, the
best solution was the three-cluster solution when all MMPI-2 scales and a method that used all
MMPI-2-RF scales were used. Thus, the three-cluster solution was considered the most adequate
solution to differentiate patients in medico-legal settings. Moreover, results demonstrated that
subgroup membership was not conditioned to spine related organic factors. Instead, malingering,
education, ethnic background and legal status differentiated pain subgroups. Lastly, results
demonstrated a dose-response relationship between perceived outcome and subgroup profile
elevation. The current results are relevant for understanding the circumstances that can influence
spine pain recovery and for informing decisions regarding possible interventions.
Keywords: MMPI-2; MMPI-2-RF; spine pain, disability, psychological overlay, cluster analysis,
pre-surgical screening, malingering.
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INTRODUCTION
Patients with primary complaints of spine pain often present with a number of symptoms
and disabilities that result in a great deal of patient’s suffering and economic loss. Although
spine pain has been typically considered a “medical illness”, the presence of physical pathology
does not reliably predict levels of pain and disability in the individual patient. As a result, there is
a growing interest in the role of different psychosocial factors in the experience and adaptation to
pain. Among these, somatization, emotional distress, and financial compensation are described
as some of the most important predictors of pain related disability and further examination on
their role in pain outcome would likely guide interventions.
The Minnesota Multiphasic Personality Inventory (MMPI) and its second version, the
MMPI-2, are widely-recognized and reliable measures of psychological problems, including
somatization and emotional distress. These instruments also contain a number of validity scales
that are shown to be reliable in identifying manipulation of the patient’s clinical presentation,
including the identification of those patients that intentionally exaggerate their report to obtain
significant financial reward (i.e. malingering). Thus, these instruments are often used to both,
describe the psychological differences among those patients with good and poor pain outcome,
and distinguish between pain patients with valid profiles and those that exaggerate their report.
Previous cluster analytic studies using the MMPI and MMPI-2 traditional validity and
standard clinical scales describe psychologically different subgroups of pain patients. These
subgroups have been shown valuable in determining patient response to treatment and in
decision-making regarding whether to perform surgery. However, there is limited application of
these results to pain populations where patients are involved in legally compensable events. This
is because previous studies do not describe important medico-legal factors which may have large
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effects in symptom endorsement (e.g., injury characteristics, legal representation or malingering
status) and do not use all the available validity scales. Using three methods of clustering, the
current investigation explored the stability of MMPI-2 subgroup solutions in a large and welldescribed population of spine pain patients that are involved in legally-compensable processes.
This investigation also expands previous investigations by adding to the clusters analyses the
recently developed MMPI-2 validity scales and the MMPI-2 restructured form (MMPI-2-RF)
clinical (RC) and validity scales. The results from the current investigation are expected to
increase the clinical application of the MMPI-2 and the MMPI-2-RF in medico-legal pain
populations.
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CHAPTER I
Pain and Disability
Spine pain, which is pain originating in the back and/or neck, is an extremely prevalent
condition. The lifetime occurrence of back pain is 11 to 84 percent (Walker, 2000), while neck
pain occurs in 10 to 15 percent of the population (Hardin & Halla, 1995). It is estimated that 70
million Americans experience some form of acute, recurrent, or chronic spine pain each year and
that 10 percent of the population report the presence of spine pain at least 100 days a year
(Cassidy, Cote, Carroll, & Kristman, 2005; Covington, 2007). Spine pain complaints result in
millions of physician office visits per year (Hing, Cherry & Woodwell, 2006), and as many as
150 million lost work days (Guo, Tanaka, Halperin, & Cameron, 1999). Given its impact it has
become increasingly important to study the factors that influence pain perception and pain
related disability.
In 1979, the International Association for the Study of Pain (IASP) published its first
working definition of pain : “An unpleasant sensory and emotional experience associated with
actual or potential tissue damage, or described in terms of such damage” (p. 249, Fields, 1987).
Based on this definition, pain has two functions: It serves as a signal to warn of danger or tissue
damage; and it compels individuals to avoid worsening the damage, allowing the process of
restoration of damaged tissues to begin (DeLeo, 2006). However, in some individuals, pain can
be an extremely debilitating problem as it has been reported to create “suffering” in patients and
families as its result (Aronoff, 1991).
Chronic spine pain, especially, has a high impact on the sufferer’s everyday functioning,
as a range of their activities are often severely limited, leading to difficulties with daily chores,
social life, and work (Abdel-Moty et al., 1993; Aronoff, 1991; Faucett & McCarthy, 2003;
3

Nurmikko, Nash, & Wiles, 1998).Chronic pain disability is defined as “diminished capacity for
everyday activities and gainful employment” or the “limitation of a patient’s performance
compared to a fit person’s of the same demographic characteristics” (e.g. age, gender; p. 24;
Gatchel, 2006). The total economic load of chronic pain-related disability in the U.S. is reported
to exceed $150 billion a year (Gatchel & Okifuji, 2006; Mayer, Gatchel, & Polatin, 2000). Thus,
determination of the factors that influence chronic spine pain and related outcome is practically
important for both a patient care and an economical standpoint.
Individual Differences in Pain and Disability
There are remarkable individual differences when it comes to perceiving and recovery
from spine pain. These individual differences are quite understandable when one acknowledges
that pain and disability are interdependent and complex experiences influenced by multiple
interactive biopsychosocial processes (Gatchel, Peng, Peters, Fuchs, & Turk, 2007). Especially
when one considers the multitude of biological and psychosocial factors that increase/decrease
individual recovery time including vulnerability to nociception, tissue healing, pain
sensation/report, as well as factors that affect the ability of the individual to cope effectively with
the challenges faced during recovery (Gatchel et al., 2007). Specifically, pain recovery is
influenced by a range of pre-and post- injury medical, biological, psychological and social
factors, which interact with injury, pain perception, and demographic characteristics to modulate
individual report of symptoms and subsequent disabilities (Gatchel et al., 2008).
Physical Pathology and Spine Pain
Physical pathology has important contributions to spine pain and disability (Ochoa,
2002). For example, herniated nucleus pulposus, foraminal stenosis, and nerve root impingement
are all associated with pain generation (Burchiel, 2002). Other common spine pathologies that
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result in pain include facet joint disorders, vertebral fracture, and musculo-ligamentous injuries
(see Appendix A for brief descriptions of selected conditions).
However, in chronic pain only a small proportion of pain perception and disability can be
attributed to physical pathology (Gatchel, Peng, Peters, Fuchs & Turk, 2007; Gatchel & Okifuji,
2006; Waddell, Pilowsky, & Bond, 1989; Tait, 1990). Also, nearly 40% of chronic pain patients
seen in primary care clinics do not benefit from traditional pain/surgical procedures suggesting
that modification of the physical pathology does not always alleviate pain/disability (Block et al.,
2003). Thus, in an important number of chronic pain patients, pathophysiology does not have a
direct causal relationship with pain perception/disability, nor does it reliably predict who will
have pain in the future.
Psychosocial Factors in Spine Pain
Recent research has implicated that a number of psychosocial factors are related to poor
pain outcome, especially in the transition between acute and chronic pain. The following sections
discuss the impact of somatization, emotional distress, and financial incentive on individual
differences of spine pain symptomatology and recovery. These psychosocial factors were
selected for review because they are often assessed in comprehensive psychological pain
evaluations.
Somatization
Somatization, and related terms (e.g. somatoform disorder), is a central factor in
understanding pain and disability attributed to pain (Allen, Gara, Escobar, Waitzkin, & Silver,
2001; Lamberty, 2008). Somatization refers to the way “certain patients use their physical
symptoms as a way of dealing with, and communicating about, their emotional lives . . . in this
type of symptom magnification, physical symptoms may be easier to accept as causing current
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unhappiness and discontent than admitting that some psychological reason is contributing to it”
(Gatchel, 2004; p. 204). In other words, somatization is the expression of psychological
problems or stress manifested in physical symptoms and complaints.
Several empirical and review studies demonstrate that patients with high levels of
measured somatization report higher levels of pain perception and significant disabilities in
daily chores, social life, and work (e.g., Bacon et al., 1994; Birket-Smith, 2001; Shorter, 1997).
Furthermore, high levels of somatization are found to predict greater perceived disability one
year after the injury above and beyond injury characteristics (Gatchel, Polantin, Mayer & Garcy,
1994), and are likely to have poor response to surgery and conservative care (Block,
Vanharanta, Ohnmeiss, & Guyer, 1996).This demonstrates that somatization is not a pure
physiological phenomenon, but is a result of the psychological mechanisms of pain. In short,
somatization may be viewed as a potentially maladaptive trait or coping style that contributes to
excess pain symptoms and pain-related disability.
Emotional distress
People who experience chronic pain also experience a wide variety of associated
emotions (Gaskin, Greene, Robinson, & Geisser, 1992). The most common emotional problems
are depression and anxiety disorders, which occur in 30% to 84% and 14 to 40% of chronic pain
patients, respectively (Arnow et al., 2006; Aguera, Failde, Cervilla, Diaz-Fernandez & Mico,
2010; Gaskin, Greene, Robinson & Geisser, 1992; Manchikanti et al., 2002).
A number of studies reveal a significant relationship between self-reported pain intensity
and depressive symptoms (Carleton, Abrams, Kachur & Asmundson; Hoff, Palermo, Schluchter,
Zebracki & Drotar, 2006; Weijenborg, Ter Kuile, Gopie & Spinhoven, 2009). Levels of
depression are recognized to have a direct relation to nociception and inverse relation to tissue
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recovery (Gur et al., 2002). Moreover, patients with high numbers of helplessness behaviors and
catastrophizing thoughts - key elements of depression - also report significantly more pain than
other patients with similar injury characteristics but fewer depression symptoms (Arnow et al.,
2006; Bair et al., 2008; Borsbo et al., 2008; Geisser et al., 1994; Roth, Lowery & Hamill, 2004).
In an important study, Holzberg, Robinson, Geisser, and Gremillion (1996) demonstrated that
self- reported disability was directly influenced by levels of depression, whereas pain levels did
not have a direct effect on self-report of function.
It is also common for patients with pain to be anxious and worried. People with chronic
pain may be anxious about the meaning of their symptoms and for their futures (Gatchel, 2004).
People with pain also experience anxiety about partaking in activities that may exacerbate their
symptoms (Bair et al., 2008). Clinical levels of anxiety may significantly increase the perceived
intensity of painful stimuli by directly impacting the physiological aspects that contribute to pain
perception (Colloca & Benedetti, 2007). Excessive anxiety may also negatively impact outcome
during treatment or following surgery by increasing avoidance behaviors, as higher level of
anxiety is associated with lack of cooperation during rehabilitation sessions and hypervigilance
to the occurrence of pain (Robb, Williams, Duvivier & Newham, 2006; Vadalouca et al., 2009;
Velanovich, 2006).
Levels of catastrophization
Patients’ overestimation of the association between physical symptoms and negative
outcomes (i.e. catastrophization ) is central to most models of poor outcome after pain injury
(Severeijns, Vlaeyen, van den Hout, & Weber, 2001). Catastrophizing is a cognitive process that
refers to a tendency to emphasize and exaggerate the negative appraisal of current or future
situations (Sullivan & D'Eon, 1990). Pain catastrophizing has been shown to be a mediator of the
relationship between negative emotions and illness behaviors and recovery, which suggest that
7

catastrophizing is the core determinant of entering into a negative pain-disability cycle (Lackner
& Quigley, 2005). Factor analytic studies have revealed three primary components of pain
catastrophizing: magnification, rumination, and helplessness (Van Damme, Crombez, Bijttebier,
Goubert, & Van Houdenhove, 2002).
The evidence for the role of catastrophization and its components in outcome after
painful injuries is overwhelming and has been summarized in several reviews (Block & Brock,
2008; Jensen, Turner, & Romano, 2001; Leeuw et al., 2007). Cross-sectional studies across
clinical and non-clinical populations have demonstrated that subjects with high levels of
catastrophization show increased pain, lower treatment benefits, and physical and psychological
dysfunctions ( Epker & Block, 2001; Edwards, Smith, Stonerock, & Haythornthwaite, 2006;
Martorella, Cote, & Choiniere, 2008; Turner, Jensen, Warms, & Cardenas, 2002). Prospective
studies indicated that levels of catastrophization may predict the development of chronic
musculoskeletal pain in the general population ( Myers et al., 2008) and of more intense pain and
slower recovery after a spine injury and surgical interventions (Granot & Lavee, 2005; Block et
al., 2008). Catastrophization has also been shown to be a significant predictor of illness
behaviors, a core component of disability, despite some overlap with emotional distress (Sullivan
et al., 1990).There is evidence that pain catastrophization is a precursor to the development of
pain-related fear (Leeuw et al., 2007).Moreover, several studies have shown that cognitive
restructuring therapy for catastrophization can reduce pain intensity and improve pain outcome (
Hanley, Raichle, Jensen & Cardenas, 2008). Thus, levels and treatment of catastrophization have
shown to be key elements in individual recovery from painful injuries.
Pre or Post Morbid Debate
Although the existence of diagnosable psychological overlay among those patients with
poor pain outcome is certain, the etiology of such problem is controversial (Gamsa, 1990). Some
8

researchers have argued that psychological disturbances are primarily a reaction to the injury and
pain (Gamsa, 1994). This is supported by early studies that reported an increase in emotional
distress after an injury (Gamsa & Vikis-Freibergs, 1991) and studies that reported that treatmentrelated pain relief is accompanied by a reduction in emotional difficulty (Snow, Gusmorino,
Pinter, Jimenez, & Rosenblum, 1988; Stein, Peri, Edelstein, Elizur & Floman, 1996).
Psychological problems are also theorized to predispose patients to have poor outcome
after a painful injury. This is supported by longitudinal studies reporting that individuals with
documented pre- injury depressive emotions and anxiety tend to interpret a given sensation as
painful and are prone to develop pain problems (for review see, Gatchel, Polantin & Mayer,
1995). For example, Bigos, Battie and Fisher (1991) found that individuals with high levels of
depression were at a significantly higher risk of developing occupational back complaints over a
four year period compared to those without such elevations. Holzberg, Robinson, Geisser and
Gremillion (1994) also found that pre-injury anxiety and depression were included among the
factors that have the most important influence, above and beyond physical abnormalities, of
future pain and pain-outcome.
Further, several studies have demonstrated that patients that report a number of
psychological problems preceding spine injury have poorer reaction to spine surgery (for review
see Block, 1996 and Block, 2002). Block, Ohnmeiss, Guyer, Rashbaum and Hochschuler (2001)
also found that psychological treatment prior to the spine injury contributed significantly to
reduce surgical outcome. In summary, whether pre or post-injury, emotional stability is an
essential part of recovery from spine pain. Therefore, measuring distress very likely helps the
determination of patients that are “at risk” for poor pain recovery by pointing out the origin of
symptoms and disabilities, as well as potential treatment effectiveness.
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Compensation
Patients who are in pain have many reasons to seek legal recourse (Hing, Cherry &
Woodwell, 2006). Often pain make patients unable to work or significantly decreases their
ability to function in their jobs (Guo et al., 1995; Guo, Tanaka, Halperin, & Cameron,
1999).Social security disability benefits, workers’ compensation and/or litigation may be the
only way to regain some of their lost income. In fact, spine pain is the most common reason for
filing a workers’ compensation claim (Guo et al., 1999).
Compensation settings are often complex and stressful psychosocial environments which
may aggravate pain problems. In general, patients seen in financially-compensatory contexts
report significantly more pain, depression, disability, as well as a decreased treatment efficacy
and productivity (Harris et al., 2005; Rainville, Sobel, Hartigan, Monlux & Bean, 1997; Rohling,
Binder, & Langhinrichsen-Rohling, 1995; Vaccaro, Ring, Scuderi, Cohen, & Garfin, 1997) even
when compared to patients with similar spine pathologies who are not in financially
compensatory contexts (Atlas et al., 2000 & Atlas et al., 2006).
There are several factors from which compensation (or the process of getting
compensated) can negatively impact outcome (Teasell, 2001). Workplace-relate factors, such a
blaming the employer for the injury, job dissatisfaction, and occupational stress have been
reported to negatively influence recovery (Guo, 2002; Hagen et al., 2002; Menzel, 2007; Shaw et
al., 2005). Delays of treatment caused by workers’ compensation regulations can also increase
the extent of the injury or the time required for recovery (Rich, 2008). Moreover, financial stress
caused by the injury can divert the patient’s focus away from rehabilitation efforts and instead
place it on economic survival (Ballamy, 1997).
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Malingering
However, there is evidence that at least some of the negative relationship between
compensation and outcome is due to patients’ intentional exaggeration of symptoms and
disabilities. Important base rate studies report a sizeable minority of compensable pain patients
(20% to 50%) intentionally exaggerate their clinical presentation in order to obtain significant
monetary reward (i.e. malingering; Greve, Ord, Bianchini & Curtis, 2009; Mittenberg et al
2002). These rates are consistent among different compensated populations such as social
security disability evaluations (Chafetz, 2008), toxic exposure (Greve, Bianchini, Black et al.,
2006), and traumatic brain injury (Larrabee, 2003). Thus suggesting that malingering in medicolegal settings is not a rare phenomenon and should be taken into consideration.
Malingering becomes a problem when determining proper intervention as it can
potentially lead to inaccurate conclusions regarding the patient’s status. As such, researchers
have developed ways to better identify those that are malingering. One such classification
method that has been recently developed is the Malingering Pain Related Disability criteria
(MPRD; Bianchini, Greve & Glynn, 2005). MPRD is defined as “the intentional exaggeration or
fabrication of cognitive, emotional, behavioral, or physical dysfunction attributed to pain for the
purposes of obtaining financial gain, to avoid work, or to obtain drugs (Bianchini, et al., 2005).
There are three key points of the criteria; first, is that malingerers intentionally over report
symptoms and disabilities due to external incentives; second, is that malingerers may present
symptoms and/or impairments in multiple ways and; third, malingering relates not only to
symptoms but also to the disability that is attributed to the pain (Bianchini et al., 2005). Thus,
Bianchini et al. (2005) suggest that when determining that a specific subject is malingering one
requires to evaluate “intent” in a comprehensive manner by considering multiple, highly
improbable events (e.g. symptoms, disabilities, behaviors). Therefore, using the Bianchini et al.
11

(2005) MPRD criteria to identify or rule out malingering in both clinical or research settings
would likely maximize confidence that results of psychological measures, diagnoses, and
recommendations are based on the legitimate problems/concerns of the pain patient.
Summary
Spine pain and disability affect, and are affected by, multiple interactive biomedical and
psychosocial factors. In the psychosocial area, somatization, chatasthrophization, emotional
distress, and financial compensation have proven to negatively impact recovery. Malingering
must also be taken into consideration, as an important number of compensated pain patients
exaggerate their symptom and disability reports to obtain financial awards. Thus, it is important
to have reliable measures that can help identify the individual problems or concerns of the pain
patient while considering altered patient symptom presentation. Reliable assessment of
psychosocial factors of pain could potentially help determine the best possible intervention for
the individual patient as well as to help cut enormous costs involved in medico-legal pain
management approaches.
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CHAPTER II
The Minnesota Multiphasic Personality Inventory
The Minnesota Multiphasic Personality Inventory (MMPI; Hathaway & McKinley, 1943)
and its revision: The Minnesota Multiphasic Personality Inventory-second edition (MMPI-2;
Butcher, Dahlstrom, Graham, Tallegen & Kraemmer, 1989), are the most widely-used measures
to study psychological disturbances including somatization, depression, and anxiety in pain
settings and other health areas (Keller & Butcher, 1991; Rabin, Barr & Burton, 2005). The
widespread use of the original MMPI and MMPI-2 in these settings is attributable to several
factors, including their simplicity of scoring and administration, an objective response format
important for research designs, manuals with useful applications, and thousands of empiricallyestablished investigations (for review see; Butcher & William, 2000; Friedman, Lewak, Nichols
& Webb, 2001; Graham, 2006).
Original MMPI
The original MMPI consists in 566- true- false items which result in three traditional
validity scales and ten standard clinical scales (Hathaway & McKinley, 1943). The validity
scales were included in the original MMPI to assist in recognizing test records produced by
uncooperative or deceptive participants with different test-taking attitudes (e.g. under-reporting
or over-reporting of symptoms) or participants who have difficulty comprehending the test items.
The clinical scales were developed primarily to assist in determining the type and severity of
psychiatric conditions. A secondary goal of the standard clinical scales was to provide an
objective means of estimating therapeutic effects and other changes in the status of patient’s
conditions across time (Dahlstrom, Welsh, & Dalstrom, 1972; Keller & Butcher, 1991).
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Traditional Validity Scales
The traditional validity scales created by Hathaway and McKinley (1943) in the original
MMPI are: the Cannot Say score, the L (Lie) scale, the F (Infrequency) scale, and the K
(Correction) scale. The Cannot Say score is the number of items that either are omitted or are
answered as both true and false. It is important to assess the Cannot Say score because omission
of many items will invalidate the test. The L scale was designed to spot individuals who present
in overly favorable way (Meehl & Hathaway, 1946). Patients who have a high L score may have
difficulty admitting even minor flaws. The F scale was designed to recognize unusual, deviant,
and atypical ways of approaching the MMPI test items (Meehl & Hathaway, 1946). Graham
(1993) described three important functions of the F scale: 1) recognizing abnormal test-taking
sets; 2) gauging the severity of psychopathology; and 3) suggesting other clinically-relevant
information about an individual. The K scale was developed to detect individuals who attempt to
portray themselves in either an overly favorable or unfavorable manner (Meehl & Hathaway,
1946). Elevated scores can suggest defensiveness; lower scores can suggest a perceive inability
to manage difficult circumstances (Graham, 1993).
Some MMPI users consider a protocol invalid or non-interpretable if it has more than 30
omitted items or has a T score greater than 70 on Scales L and K (Graham, 1993). For Scale F,
score at or above 90 increases the possibility of an invalidating response set due to symptom
over-reporting. However, scores at or above this level in Scale F could also suggest serious
psychopathology (Graham, 1993).
Standard Clinical Scales
Since the MMPI’s publication, hundreds of studies have examined the relationship
between the clinical scales and relevant extra-test characteristics, such as symptoms personality
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traits, diagnosis, and response to treatment. These studies were conducted in a variety of
nonclinical, mental health, and correctional settings (for a comprehensive review see, Butcher,
1989).The gathered results suggest that the MMPI clinical scales are meaningfully related to
conceptually relevant extra-test characteristics. For example, individuals with elevated scores in
Scale 1 (Hypochondriasis) often demonstrate somatic concerns, somatic symptoms, and
undefined complains, such as gastric upset, fatigue, pain, and physical weakness. High scorers on
Scale 2 (Depression) are seen as depressed, unhappy, dysphonic, pessimistic, and sluggish.
Individual who score high on Scale 3 (Hysteria) tend to react to stress by developing physical
symptoms such as headaches, chest pains, weakness and tachycardia. These individuals
sometimes develop physical problems in reaction to stress (Graham, 1993). Classically,
elevations on Scales 1 and 3 have been ascribed to somatization (Block et al, 2003; Blumetti &
Modesti, 1976; Friedman, Gleser, Smeltzer, Wakefield, & Schwartz, 1983; Marks & Seeman,
1963), while Scales 2 and 7 have been linked to depression and anxiety, respectively (Graham,
2006).
In general, clinical scales with T scores equal or greater than 70 are considered clinicallyelevated in the original MMPI. However, higher scores are associated with more severe
symptoms and problems (e.g. depression for Scale 2). A study by Graham, Ben-Porath, Forbey,
and Sellbom (2003) using the MMPI-2 supported this notion. Patients with very high scores on
the clinical scales had more severe symptoms and problems than those with moderately high
scores.
The Minnesota Multiphasic Personality Inventory-2
In 1989, the original MMPI was revised into the MMPI-2. One goal of the MMPI-2 was
to preserve the established original MMPI clinical correlates while expanding the item pool to
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cover additional areas (Butcher, et al., 1989; Keller & Butcher, 1991). Items that had
objectionable content were removed or rewritten. New items were added to cover content areas
that were underrepresented in the original MMPI. In its final form, the MMPI-2 has 567 items
and item membership of the traditional validity (L, F and K) and standard scales (1-0) are largely
equivalent to the original MMPI (Butcher et al., 1989). As discussed by Keller and Butcher
(1991), the largest difference between the MMPI and the MMPI-2 are likely result from
differences in norming procedures. The other major difference is that the scores for standard
clinical scales were considered elevated at or above T score 65, instead of 70 (Keller & Butcher,
1991).Validity scales are generally considered elevated at or above T score 75 (Graham, 2006).
Although the MMPI-2 has not been revised since its publication in 1989, several
developments should be noted. New scales were created to determine inconsistent responding,
and under- or over- reporting of symptoms (discussed below; Graham, 2006). Another recent
development after the publication of the MMPI-2 is the development of the Restructured Clinical
(RC) scales (Tallegen et al., 2003) and the RF validity scales, which now comprise the compose
Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF; Tallegen &
Ben-Porath, 2008). For a description of all validity and clinical scales refer to Table
1.Descriptions and discussion of these new scales is presented next.
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Table 1
Minnesota Multiphasic Personality Inventory-2nd edition Scales
Validity Scales
Infrequent responses in the general population
Infrequency
first half of the test
F
Infrequent responses in the general population
Infrequency back
Fb
second half of the test
Infrequency
Infrequent responses in psychiatric population
Fp
psychopathology
Symptom Validity
Non-credible somatic and cognitive complains
Scale
FBS
L
K
S
Clinical Scales
1
2
3
4
5
6
7
8

Lie
Correction

Uncommonly high levels of psychological
adjustment

Self-Presentation

Defensiveness presentation

Hypochondriasis

Somatic concerns, somatic symptoms, and
undefined complains

Depression

Depressed, unhappy, dysphonic, pessimistic,
and sluggish.

Hysteria

Reaction to stress by developing physical
symptoms

Psychopathic Deviate

Antisocial behavior, rebellious attitudes.

Masculinity-Femininity Gender interests
Paranoia

Reactions of others, suspicious and guarded,
and are hostile, resentful, and argumentative

Psychasthenia

Tend to be anxious, tense and agitated

Schizophrenia

Psychotic behaviors, confusion,
disorganization, and disorientation.

Hypomania
9
Social Introversion
0

Uncommon virtues

Hyperactive and/or have accelerated speech
and may have hallucinations or delusions of
grandeur
Social introversion and low scores reflect social
extroversion
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MMPI-2 New Validity Scales
Inconsistent reporting Scales. Validity Response Inconsistency (VRIN; Butcher, 1989,
2001) was developed for the MMPI-2 as an additional validity indicator. It provides an
indication of a tendency to respond inconsistently to MMPI-2 items. The MMPI-2 manual
(Butcher, 1989, 2001) suggests that a T ≥ 80 indicates inconsistent responding that invalidates
the resulting protocol.True Response Inconsistency (TRIN; Butcher, 1989, 2001) was developed
for the MMPI-2 to identify persons who respond inconsistently to items giving true responses to
items indiscriminately (acquiescence) or by giving false responses to items indiscriminately
(non-acquiescence). The MMPI-2 manual also suggests that TRIN scale of T ≥ 80 indicates
inconsistent responding that invalidates the resulting protocol. Subsequent to the publication of
the MMPI-2, several empirical studies have confirmed that VRIN and TRIN scale are sensitive
to random responding (Archer, Fontaine, & McCrae, 1998; Greiffenstein, Baker, Tsushima,
Bonne, & Fox, 2010; Lees-Haley, 1997; Pinsoneault, 2007).
Under Reporting or Defensiveness. Butcher and Han (1995) developed the Superlative
Self Presentation (Scale S) to assess the tendency of some persons to present themselves on the
MMPI-2 as high virtuous, responsible individuals, who are free of psychological problems, have
few or no moral flaws, and get along extremely well with others. Butcher and Han (1995)
reported that there are five major content dimensions in the S scale items: 1) belief in human
goodness; 2) serenity, 3) contentment with life; 4) patient and denial of irritability and anger; and
5) denial of moral flaws. Higher Scale S scorers in the MMPI-2 are reported to be unrealistically
reporting positive attributes and good adjustment (Archer, Handel & Couvadelli, 2004; Butcher
& Han, 1995; Baer & Wetter, 1997; Baer & Miller, 2002).
Over-reporting. With the introduction of the MMPI-2 it was recognized that the
traditional Scale F is based on items that occur early in the booklet; thus, it did not assess the
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validity of items that appeared later in the booklet. Scale Infrequency Back (Fb; Butcher et al.,
1989, 2002) was developed to determine the validity of items appearing after item 350. Elevated
Scale Fb score could indicate that the test taker responded to items in the second half of the test
booklet in an invalid manner. It was also recognized in some clinical settings that high scores on
Scale F are often due, or at least in part, to severe psychopathology of those who take the MMPI2.Thus, Arbisi & Ben-Porath (1995) developed the Infrequency Psychopathology (Fp) scale as
supplement to the Scale F in identifying infrequent psychiatric responding. The 27 items in Scale
Fp are ones that were answered infrequently by both psychiatric inpatients and persons in the
MMPI-2 normative sample. The resulting Scale Fp is less likely to reflect psychopathology than
the Scale F items (Archer, Handel, Greene, Baer & Elkins, 2001).
Specifically for personal injury claimants, Lees-Haley, English, and Glenn (1991)
developed the Symptom Validity Scale (FBS) to detect invalid responding of emotional distress.
FBS is probably the best studied and validated scale across a range of medical and psychological
conditions (For reviews see, Greiffenstein, Fox, & Lees-Haley, 2006; Nelson, Sweet, &
Demakis, 2006 ). FBS is sensitive to a response set that is goal directed and designed to:1)
appear psychologically normal except for the influence of the alleged injury; 2) minimize preinjury psychopathology; and 3) appear honest and present a plausible degree of injury or
disability (Larrabee, 1998).
The over-reporting validity scales (including Scale F) of the MMPI-2 are effective in
identifying persons who intentionally exaggerate their symptoms (for reviews see in particular
Rogers, Sewell, Martin, & Vitacco, 2003, and Lees-Haley, Iverson, Lange, Fox, & Allen, 2003).
The MMPI-2 validity scales have been shown effective in differentiating non-clinical
individuals, typically college students, who took the test under standard instructions from those
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instructed to malinger (simulators; e.g., Berry et al., 1996). Later studies have also demonstrated
that the over-reporting validity scales can differentiate known-malingerers from other types of
responding. Larrabee (2003), Greve et al. (2006), and Bianchini et al. (2008), for instance, used a
criterion validation (or known groups) design to determine the classification accuracy of a
number of MMPI-2 validity scales and indicators in the detection of cognitive malingering in
traumatic brain injury (TBI) and pain-related disability (PRD), and demonstrated the ability of
these scales to accurately differentiate non-malingerers from malingerers. Note that the above
studies involved patients with similar levels of physical pathology suggesting that differences in
malingering classification explained the differences in MMPI-2 scores.
The Minnesota Multiphasic Personality Invetory-2-Restructured Form
The Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF;
Tellegen & Ben-Porath, 2008) is now offered as alternative to the MMPI-2. The MMPI-2-RF
was developed to be a less time-consuming update of the MMPI-2 (Tellegen & Ben-Porath,
2008). The restructured form consists of 338 items. The MMPI-2-RF has no new or changed
items, nor has it been re-standardized. Instead, the original standardization sample from the
MMPI-2 was used to construct or restructure 50 new and revised scales, with the Restructured
Clinical (RC) and the restructured validity scales at the core. See Table 2 for a detailed
description of the RC and RF validity scales.
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Table 2
Minnesota Multiphasic Personality Inventory-2nd edition Restructured Form
Restructured Form Validity Scales
F-r

Infrequency restructured

Fp-r

Infrequency
psychopathology
restructured

Fs

Infrequency somatic
symptoms

FBS-r
L-r

Infrequent responses in the general population
Infrequent responses in psychiatric population
infrequent somatic complains in medical
patient population

Symptom Validity Scale

Non-credible somatic and cognitive complains

Lie

Uncommon virtues
Uncommonly high levels of psychological
adjustment

K-r
Correction
Restructured Clinical Scales

General dissatisfaction, unhappiness,
hopelessness, self doubt, inefficacy
Self-reported neurological, gastrointestinal,
and pain related complains
Lack of, or incapacity to experience positive
emotions. Core vulnerability factor for
depression

RCd

Demoralization

RC1

Somatic Complains

RC2

Low Positive Emotions

RC3

Cynism

RC4

Antisocial Behavior

Non-self-referential belief in human badness
Including, juvenile misconduct, family
problems, substance misuse

RC6

Ideas of Persecution

Self-referential persecutory ideation

RC7

Dysfunctional Negative
Emotions

Including, anxiety, irritability, anger, oversensitivity, vulnerability

RC8

Aberrant Experiences

RC9

Hypomanic Activation

Unusual perceptual and thought processes
impulsivity, grandiosity, aggression, and
generalize activation

Restructured Scales
There are nine restructured clinical (RC) scales, all of which are derived from selective
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items included in the standard clinical scales. Tallegen et al., (2003) report that the RC scales for
the MMPI-2 were constructed to “preserve the important descriptive properties of the existing
MMPI-2 clinical scales while enhancing their distinctiveness” (p. 10).Initially, the authors
identified and separated items from the clinical scales that detected a “general complaint or
malaise factor (i.e. demoralization)” (p.11), and created a single scale, RCd, to separate this
nonspecific factor that seems to pervade throughout the original clinical scales. The remaining
RC scales correspond roughly with the numerical order of the MMPI-2 traditional clinical scales
(e.g. RC1 is the updated version of scale 1, Hysteria). The profile includes the Demoralization
scale (RCd), the Somatic Complains scale (RC1), the Low Positive Emotions scale (RC2), the
Cynism scale (RC3), the Antisocial Behavior scale (RC4), the Ideas of Persecution scale (RC6),
the Dysfunctional Negative Emotions scale (RC7), the Aberrant Experiences scale (RC8), and
the Hypomanic Activation scale (RC9). Standard clinical Scale 5 (Masculinity-Feminity) and
Scale 0 (Social Inhibition) are not represented in the RC scales profile (Tallegen et al., 2003).
When comparing reliability and validity of the RC scales with the clinical scales, RC
scales have demonstrated lower intercorrelations, increased reliability, and less saturation with
demoralization (Tallegen et al., 2003). The RC scales also show markedly-refined discriminant
validity and proportional, and in some cases significantly improved, convergent validity than the
standard clinical scales (Arbisi, Sellbom, & Ben-Porath, 2008; Ben-Porath & Tallegen, 2008;
Forbey & Ben-Porath, 2008; Osberg, Haseley, & Kamas, 2008; Tallegen et al., 2003). In a
comparison study, Sellbom, Ben-Portah, McNulty, Arbisi, and Graham (2006) examined the
frequency, origins, and interpretative implications of elevation differences between the RC scales
and the standard clinical scales. Analyzing data from mental health inpatients and outpatients,
they found that the RC scale and its original counterpart will more often agree than disagree as a
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dichotomous variables (i.e. elevated v. not elevated score). When differences did occur, they
were attributable in the vast majority to some combination of demoralization, the K-correction,
and subtle items to scores on the standard clinical scales. With respect to interpretative
implications of these differences, Sellbom et al., (2006) described that in cases where the
standard clinical scale is elevated but its RC counterpart was not, the patient was less likely to
present a the specific psychological problem in collateral information . Conversely, when an RC
scale was elevated and its original counterpart was not, the patient was most likely to present the
psychopathology in collateral data.
Reformed Validity
The MMPI-2-RF includes eight validity indicators, revised versions of the MMPI-2
Response Inconsitency (VRIN-r) and True Response Inconsistency (TRIN-r) scales, Uncommon
Virtues (L-r) and the Correction scale, now labeled Adjustment Validity (K-r). The MMPI-2-RF
also has four over-reporting indicators: the Infrequent Responses (F-r) scale serves as a general
over-reporting indicator and is comprised of 32 items rarely endorsed by the MMPI-2-RF
normative sample. Unlike the MMPI-2 F scale, which was developed with the original MMPI, Fr is more similar to the Fb scale of the MMPI-2, which is composed of items infrequently
endorsed in 1989 normative sample.
The Infrequent Psychopathology Responses (Fp-r) scale is the MMPI-2-RF indicator of
over-reported symptoms of severe psychopathology. Fp-r is shorter than its counterpart the
MMPI Fp, consisting of 21 items. A revised version of the Symptom Validity (FBS-r) scale is
the same as its counterpart MMPI-2 FBS, and assesses non-credible somatic and neurocognitive
complains. Finally, Somatic Response (Fs) was added to the MMPI-2-RF to measure overreporting of somatic complains using the traditional infrequency approach. Wygant, Ben-Porath,
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and Arbisi (2004) developed Fs by identifying 16 items with somatic content that were endorsed
by less than 25% of patients in two large archival medical samples and an archival chronic pain
sample.
To this end, only one study (Wygant, Ben-Porath, Arbisi et al., 2009) has specifically
used the MMPI-2-RF validity scales to differentiate intentional symptom over reporting from
other types of symptom report in financially-compensated settings. Wygant, et al., (2009)
examined the MMPI-2-RF scores of 151 personal injury and disability claimants. Out of these,
16% experienced painful injuries. Wygant and colleagues found that all four MMPI-2-RF overreporting validity scales were useful in detecting simulated and known intentional symptom
exaggeration. Specifically, these authors demonstrated all validity scales reliably differentiate
criterion-determined malingerers from not-malingering.

Summary
The MMPI and the MMPI-2 are widely recognized and reliable measures of
psychological problems and alterations in patient’s clinical presentation. These measures
traditionally contained three validity scales (L, F, and K) and ten clinical scales (1-0). With (and
after) the introduction of the MMPI-2 new scales have been developed, including scales that
measure misinterpretation of test (VRIN and TRIN), under-reporting (S) and over-reporting (Fb,
Fp and FBS) of symptoms. Moreover, shorter and divergent clinical (RC) and validity (RF
validity) were recently developed to minimize completion time as well as to reduce scale
overlap. The use of the MMPI variables have helped clarify how psychological overlay
influences pain perception and pain related outcome. Research on the MMPI in pain is presented
in the next chapter.
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CHAPTER III
The MMPI and Pain
The MMPI and MMPI-2 have been frequently and extensively used in the assessment of
patients with pain (Keller & Butcher, 1991; Snyder, 1990; Vendrig, 2000). These instruments
have been used to describe the characteristics of the typical pain patient (Costello, Hulsey,
Schoenfeld & Rammamurty, 1987; Keller and Butcher, 1991; Block, Gatchel, Deardoff &
Guyer, 2004) and to determine differences among those patients that recover from those that do
not recover to pre-injury levels (for review see Robinson, 2000 and Deardorff, 2000). Such
descriptions and determinations have been demonstrated to have relevance for a) disclosing
etiologic factors in chronic pain stages, b) guiding clinicians in development general treatment
programs, and c) predicting the development of pain problems (Butcher & Rouse, 1996; Gatchel,
2008; Block, et al., 2004).

MMPI Pain Subgroups
One important contribution of the MMPI research in pain is the description of subgroups
that differ significantly in psychological characteristics and pain-related outcome. Sternbach
(1978) originally proposed the existence of four homogeneous and distinctive pain subgroups
based on clinical appreciation profiles on the original MMPI. The patients in the first group
reported elevations on scales 1, 2, and 3, with scale 2 being the highest. This subgroup was
described as “depressive” because patients tended to be dissatisfied with their condition or
situation. The next group reported equal elevations on scales 1, 2 and 3. These patients were
categorized as “hypochondriacs” as patients were consumed by somatic concerns. A third group
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demonstrated a profile with medium elevations only on scales 1, 3 but not on Scale 2.These
patients were characterized as “Conversion V” and they did not present any particular
psychopathology. The “manipulative reactions” group was the last profile and was characterized
by multiple scale elevations, especially on Scale 4. These patients tended to be “game-player
manipulators” (p.330) and were thought to use the services of health care professionals for
secondary gain.
Subsequently, Sternbach’s ideas were tested using cluster analysis1, a more objective or
empirical method of group classification. For example, Bradley and colleagues (Bradley et al.,
1981) used hierarchical agglomerative cluster analysis on all the original MMPI scales and found
a four-cluster solution for females and three-cluster solution for males. In both sexes, a subgroup
with elevations on scales 1, 2, and 3 was common. A second common subgroup in both sexes
was one that had all scales within normal limits, although borderline elevations or less than two
standard deviations above the mean were obtained on scales K, 1 and 3. A third but less
frequently seen pattern in both sexes was multiple scale (four or more) elevations. Finally, in
women only, a group was found having elevations on scales 1 and 3 but not on scale 2.
McGill, Lawlis, Selby, Mooney, and McCoy (1983) confirmed these results examining
92 patients in an inpatient program for treatment of low back pain. The investigators reported
that they replicated the clusters solution that Bradley et al., (1983) found for men and women
alike. Moreover, the profile subgroups appeared to differ with regard to the duration of pain, the
presence of clear precipitant, the number of days in hospitalization, the number of back surgeries
and pretreatment pain estimate. Those with elevations on multiple scales consistently had worse
outcome than the other groups.
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Costello, Hulsey, Schoenfeld and Rumamurthy (1987) summarized the type profile
categorizations or cluster solutions from 10 studies on the original MMPI scales using a metaanalytic technique. Authors used the acronym PAIN to describe the different typologies of
previously found clusters (See Figure 1). Type P involved elevations on most of the clinical
scales and appeared to be the most disturbed profile. The profile was associated with difficulty in
the realms of psychological, educational, and vocational functioning. Type A was the conversion
V profile which reported no significant pain problems. Type I appeared to be a hypochondriac
profile associated with physical impairment, multiple surgical procedures, and multiple
hospitalizations. Type N patients were described as relatively normal.
Figure 1. Costello et al., (1987) illustration of cluster solution
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Note. L: Lie, F, Infrequency; K: Correction; 1: Hypochondriasis; 2: Depression; 3:
Hysteria; 4: Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 :
Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social Introversion.
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MMPI-2 Pain Subgroups
When the MMPI-2 was introduced, several researchers found important to investigate if
subgroups solutions replicate when using the newer instrument. Riley, Robinson, Geisser and
Wittmer (1993) investigated whether the MMPI-2 cluster solutions would replicate those from
the original MMPI. Riley et al. use hierarchical agglomerative clustering procedure to examine
the profiles of 201 low back pain patients using the ten clinical scales and traditional validity
Scales L, F, and K. Four homogeneous clusters were identified: the largest group with all MMPI2 scales within normal limits (“Normal”); the second largest group with elevations on Scales 1,
2, and 3 (“Triad” group); the third group with elevations on Scales 1 and 3 only (“Conversion V”
group); and a small fourth group with elevations on four or more scales (DepressedPathological”). See Figure 2 for an illustrative scale description of Riley et al. subgroups. In
general, Riley et al. confirmed the existence of four pain subgroups when using the MMPI-2.
Figure 2. Riley et al., (1993) illustration of cluster solution
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Note. L: Lie, F, Infrequency; K: Correction; 1: Hypochondriasis; 2: Depression; 3:
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Hysteria; 4: Psychopathic Deviate; 5: Masculinity-Femininity;
6: Paranoia; 7 :
Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social Introversion.

Subsequently, Riley, Robinson, Geisser, Wittmer, and Smith, (1995) tested the predictive
validity of their previously found subgroups by evaluating the outcome of 71 patients (out of the
201 group) 6 months after surgery. Results demonstrated significant differences in recovery
time. Those patients classified as “Normal” obtained significant improvements. A similar
outcome was obtained by those leveled as “Triad”. The patients leveled as “Conversion V”
achieved poorer surgical results than did the normal and triad groups. Finally, the “DepressedPathological” patients demonstrated the least improvements and diminished surgical results
among all the patients.
Gatchel, Mayer, and Eddington (2006) also support the utility of Riley’s MMPI-2 pain
sub-groups (constructed based on clinical appreciation) for predicting nonsurgical treatment
outcomes in musculoskeletal disorders. Gatchel et al. (2006) clinically classified 1,489 pain
patients into one of four Riley et al.’s subgroups based on their elevations ( T ≥ 65) on the
MMPI-2 clinical scales; and these groups were compared on socioeconomic, psychopathological,
and pain measures. Patients in the “Normal” group were twice more likely to return to work and
less likely to have psychopathological complications than the other three groups. The
“Pathological” group was 14 times more likely to report more pain and psychopathology than the
normal group. The “Triad” group was 6.6 times more likely to report pain and psychopathology
than the normal group. The “Conversion V” group did not show any significant differences from
the Normal group or the Triad group.
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Other cluster analytic studies have demonstrated somewhat similar results. Block and
Ohnmeiss (2000) also used hierarchical agglomerative clustering procedure on the MMPI-2 to
group spine surgery candidates and determine associated outcome. All patients had spinal
damage or findings. Similarly to Riley et al. study, Block and Ohnmeiss used the ten standard
clinical scales and the traditional validity Scales L, F, and K. A three-cluster solution was found
to be the best solution in examining the profiles of 222 pain patients. The described clusters
were: a within the “Normal” limits profile (n = 114) with no scale elevations, a “Pain
Sensitivity” profile (n = 86) that showed elevations in Scales 1,2 and 3 which resembles the
“Triad” group, and a “Pathological” profile (n = 22) which had elevations in four or more
MMPI-2 clinical scales resembling the Depressed-Pathological group. Interestingly, Block et al.,
did not find the typical “Conversion V” group. In terms of surgical outcome, the “Pathological”
subgroup obtained the least improvements in functional ability and pain reduction. The within
“Normal” profile achieved the best surgery results. The “Pain Sensitivity” profile reported more
pain but similar improvement in functional ability when compared to the within “Normal” limits
group.
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Figure 3. Block and Ohnmeiss (2000) illustration of cluster solution

100
95
90
85
80
75
70
65
60
55
50
45
40

Normal
Pain Sensitivity
Pathological

L F K 1

2 3 4

5 6

7

8 9 0

Note. L: Lie, F, Infrequency; K: Correction; 1: Hypochondriasis; 2: Depression; 3:
Hysteria; 4: Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 :
Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social Introversion.
Marters, Shearer, Ogles, and Schleudener (2003) examined whether empirically-derived
cluster profiles based on scores on the MMPI-2 predicted outcome of surgery one year for low
back pain. Similar to Riley et al. and Block and Ohnmeiss, this study used hierarchical
agglomerative clustering procedure on the ten standard clinical scales and the traditional validity
scales. The authors found that the best solution was the three subgroups solution. These consisted
of a “Pathological-Neurotic” type with high elevations on Scales 1,2, and 3 and medium
elevations on Scales 7 and 8, a “double V” which resembles the “Conversion V” type with
medium elevations in Scales 1 and 3, and the “Normal” type which demonstrated no elevations.
See Figure 4 for an illustrative description of Masters et al. cluster solutions. Patients in the
normal type were significantly more likely to report satisfaction with surgery and best surgical
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results than the other clusters. The “double V” group did not differ from the “PathologicalNeurotic” group in any of the outcome variables.
Figure 4. Martens et al., (2002) illustration of cluster
solution
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Hysteria; 4: Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 :
Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social Introversion.
Summary
A number of hierarchical agglomerative cluster analytic studies have helped determine
the existence pain patient subgroups that arise from common patterns of responding on the
original MMPI and the MMPI-2. These subgroups were a valuable addition in determining
differences in pain perception, and patient response to treatment, as well as in decision making
regarding whether to perform surgery. Specifically, these studies revealed a three or four
subgroup solutions describing a “Normal” group which is characterized by no clinical scales
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elevations and good outcome; a “Pathological” group characterized by multiple clinical scales
elevation and poor outcome; and “Pain Sensitivity”, “Conversion V” and/or “Triad” groups
which are distinguished by elevations in Scales 1, 3 and/or 2 and, in general, show better
outcome than the “Pathological” group but worse than the “Normal” group.
Despite the significance of previous results, the clusters were identified not taking into
consideration differences in severity and type of the physical injuries and other factors that can
influence symptom report such as financial compensation and malingering. Moreover, the above
studies only included scales L, F, and K to determine the best cluster solution not considering the
newly developed MMPI-2 validity scales. Including the new validity scales in the determination
of subgroups could further enhance the reliability of the subgroups by increasing assurance
regarding valid patient presentation of symptoms/disabilities. Thus, it is important to expand
previous studies by conducting an exploratory cluster analysis on all relevant MMPI-2 scales
over a well characterized sample in terms of the medical and legal factors that could influence
recovery to further enhance the generalization of the results.
In the same way, it is also important to investigate whether the subgroup solutions
replicate when using the newly developed MMPI-2-RF scales. Investigating whether cluster
solutions using the MMPI-2-RF scales resemble the MMPI-2 subgroups could provide a clearer
understanding of the strength of this instrument to determine psychological differences between
pain subgroups and thus, increment its utility as a diagnostic tool.

Purpose
The main goal of this investigation was to expand previous cluster analytic studies by
determining the best cluster solution using MMPI-2 and MMPI-2-RF variables on a large and
well characterized pain subgroups that were seen in medico-legal contexts. Specifically, this
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study examined, thoroughly described and compared: 1) the subgroups that arise when using the
MMPI-2 standard clinical and traditional validity scales (the traditional clustering method); 2)
the subgroups that arise when the cluster analysis is conducted also including the new validity
scales Fb, Fp and FBS (the MMPI-2 clustering method); and 3) the subgroups that arise when
conducting a cluster analysis on the recently developed MMPI-2-RF scales (the MMPI-2-RF
clustering method).

End Notes
Cluster analysis is a generic name for a variety of mathematical methods, numbering in
the hundreds, which in the behavioral sciences are often used to group patients that have similar
data.
1
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CHAPTER IV
METHODS
Participants
Patients were culled from the archival records of a pull of approximately 847 sequential
cases seen for psychological pain evaluations at a large clinical psychology practice in the
Southeastern United States from 1998 through 2008. All patients were referred by physicians,
workers compensation companies, and attorneys. Extensive medical records were reviewed in
the context of these evaluations to provide objective medical diagnostic test results, as well as
physicians’ clinical diagnoses and injury descriptions. The inclusion criteria were: 1) referral for
persisting spine pain-related complaints, 2) presence of significant external incentive primarily in
the form of workers’ compensation claims or a personal injury law suit, and 3) completion of the
MMPI-2. Because all items of the MMPI-2-RF are included in the MMPI-2, it was possible to
score MMPI-2-RF scales for all those patients that have all MMPI-2 items available. Exclusion
criteria were: 1) age lower than 18 and greater than 59; 2) time since injury of less than 6 months
or more than 15 years; 3) a head injury accident more severe than a concussion (as defined by the
Mild Traumatic Brain Injury Committee of the Head Injury Interdisciplinary Special Interest
Group of the American Congress of Rehabilitation Medicine, 1993). Finally, patients were
screened according to their MMPI-2 VRIN scale, TRIN scale and Cannot Say score. Cases were
excluded if VRIN or TRIN are greater or equal 80 or Cannot Say is equal or greater than 30
(Butcher et al., 1989).
The final sample was comprised of 608 cases. The mean age for the full sample was 42.4
years (sd = 8.8). The sample had completed an average of 11.7 years of education (sd = 2.5) and
were 38.2 months post injury (sd = 29.3). The sample was 64.6% male and 65.6% Caucasian
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(African-American = 28.1%; other or not indicated = 5.3%). At the time of the interview the
patients rated their pain at 6.7 (sd = 1.9) out of a maximum of 10. Less than half (40.5 %) of
patients had objective evidence of pathology involving the spine or spinal cord. Spine surgery
was present in a quarter to one third of cases. Comorbid pain syndromes (e.g., fibromyalgia,
complex regional pain syndrome) were rare (less than 10%).
Of the full sample, patients had external incentive primarily in the form of workers
compensation claims (82.6%) or a personal injury law suit (15.3%). Over half (55.9%) were
represented by an attorney though less than a quarter (23.8%) were attorney-referred. The
remainder were referred by clinicians (usually medical doctors; 28.8%) or case managers /
adjusters (47.8%). Based on Bianchini et al. (2005) Malingered Pain-Related Disability (MPRD)
criteria, 37.2% were classified as Not MPRD, 29.9% were Possible MPRD, 25.3% were
Probable MPRD and 7.6% were Definite MPRD.

Measures, Variables and Characterization
MMPI Variables
The Minnesota Multiphasic Personality Inventory 2nd edition (MMPI-2; Butcher et al.
1989) is a widely used emotion and personality measure. The MMPI-2 consists of 567 items.
Variables that were used in this study are validity scales: Cannot Say, VRIN, TRIN, L, F, Fb, Fp,
FBS and K, (scale S was not included because it was not collected for all patients); and clinical
scales 1 thru 0. Refer back to Table 1 for a detailed description of the MMPI-2 clinical and
validity scales.
T-scores were analyzed for all variables. Based on manual recommended interpretation
cutoffs, T scores were classified as May be exaggerated or May be invalid for all for validity
scales and High or Very high scores for all clinical scales. See Table 3 for T scores classification
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categories by MMPI-2 scale. For details regarding cutoff, scales and indicators, the reader is
referred to the MMPI-2 manual (Butcher et al., 1989) and Lees-Haley et al. (2003) as well as
other standard MMPI-2 texts (e.g., Greene, 2000; Graham, 1990; Freidman, Lewak, Nichols, &
Webb, 2001).
Table 3
T scores at or above (≥) the interpretative cutoff based on the Lees-Haley et al. (2003) MMPI-2
manual
Validity Scales
May be exaggerated
May be invalid
F
70
90
Fb
80
90
Fp
70
100
FBS
80
100
L
65
80
K
-65
Clinical Scales
All Clinical Scales (1-0)

High
65

Very High
75

Note. F: Infrequency; Fb: Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom
Validity scale; L: Lie; K: Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4:
Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 :
Hypomania; 0 : Social Introversion.

The Minnesota Multiphasic Personality Inventory 2nd edition-Restructured Form (MMPI-2RF; Ben-Porath and Tallegen, 2008). The restructured form consists of 338 items. Variables that
were used in this study are RF validity scales: L-r, K-r, F-r, Fp-r, Fs and FBS-r; and clinical
scales: RCd thru RC9. Refer back to Table 2 for a detailed description of the RC and RF validity
scales. T-scores were analyzed for all variables.
T-scores were analyzed for all variables. Based on manual recommended interpretation
cutoffs, T scores were classified as Maybe exaggerated or May be invalid for all for validity
scales and High or Very high for all clinical scales. See Table 4 for Diagnostic Cutoffs by
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MMPI-2-RF scale. For details regarding cutoffs, scales and indicators, the reader is referred to
the MMPI-2-RF manual (Ben-Porath and Tallegen, 2008).
Table 4
T scores at or above (≥) the interpretative cutoff based on the Ben-Porath and Tallegen ( 2008)
MMPI-2-RF Manual
RF Validity Scales
F-r
Fp-r
Fs
FBS-r
L-r
K-r

May be exaggerated
90
70
80
80
70
66

May be invalid
100
80
90
90
80
70

High

Very high

65

80

Clinical Scales
All RC Scales (RCd-RC9)

Note. F-r: Infrequency restructured; Fp-r: Infrequency psychopathology restructured; Fs:
Infrequency somatic symptoms; FBS-r: Symptom Validity scale restructured; L: Lie restructured; K:
Correction restructured; scales RCd-RC9: RCd: Demoralization; RC1: Somatic Complains; RC2: Low
Positive Emtions; RC3: Cynism; RC4: Antisocial Behavior; RC6: Ideas of Persecution;RC7:
Dysfunctional Negative Emotions; RC8: Aberrant Experiences; RC9: Hypomanic Activation.

Non-MMPI variables
Demographics variables that were examined in this study are age, gender, education
level, race, time since injury.
Symptom/Injury characteristics variables that were examined are pain symptoms by area of
the body, spine findings, spinal surgery and other pain-related diagnoses. In addition, an Injury
Severity scale was created to serve as a rough linear approximation of the degree or severity of
spine-related medical findings. Based on a review of medical records each case was assigned a
score of 0 to 4 as follows: no findings = 0; degenerative disc(s) or joint(s) = 1; bulging or
protruding disc(s) = 2; herniated disc(s) = 3; and 4) neural impingement(s) = 4. Note that spine
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severity scores were not cumulative; patients received the highest single score for which findings
were observed.
Medico-legal variables that were examined are status of legal representation, referral source,
and claim type. Malingering status was also described for all patients. Malingering status was
based on the criteria for the diagnosis of MPRD (Bianchini et al., 2005). Classification relied on
performance on psychometric indicators and examination of available records. Patients were
classified as MPRD based on two criteria. MPRDa was based on performance on psychometric
indicators not including the MMPI-2 variables. MPRDb was based on performance on
psychometric indicators including the MMPI-2 variables. See appendix C for a description of
psychometric indicators, cutoffs and operationalization of the malingering classification systems.
This system results in patients being classified into one of four groups: 1) Not MPRD; 2)
Possible MPRD (some findings but insufficient for a higher level diagnosis); 3) Probable MPRD;
4) “Definite MPRD”. “Definite MPRD” is defined by the presence of a significantly belowchance finding. “Probable MPRD” is defined in terms of two or more psychometric findings
consistent with malingering or two or more qualitative inconsistencies along with one or more
psychometric findings. Cases that had psychometric findings or two or more qualitative
inconsistencies but who did not meet these criteria were considered “Possible MPRD”. Cases
who do not meet any of the above criteria were classified as “Not MPRD.” Finally, the Probable
and Definite MPRD patients were combined as “All MPRD” group as both are considered
malingering in the MPRD criteria.
Pain Perception and Predictors of Outcome variables
Pain Perception was examined by patients’ report of their level of pain on a scale ranging
from 0 (No Pain) to 10 (Worst Pain Imaginable) at the time of the interview (current), when they
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had the least amount of pain (best) and when they had the most amount of pain (worst) after the
injury.
The Pain Catastrophizing Scale (PCS; Sullivan et al., 1995) was be used to measure the
construct of pain catastrophization which includes a hypervigilance, threat magnification, and
feeling of helplessness related to pain. PCS consists of 13 statements related to pain that are each
rated (0-4) as to the degree felt during painful experiences. PCS T scores were used in this study.
It is important note that the PCS was introduced to the psychological practice in 2005 and only
140 patients included in this study have scores.
Perceived Disability was measure using the Pain Disability Index (PDI; Pollard, 1984)
assesses pain disability in seven areas (occupational, home/family, recreational, social, sexual,
activities of daily living, life support), all rated on 11-point Likert-type scales (0, no disability;
10, complete disability ; see appendix B). Raw scores were used for this study because T scores
were not available. The PDI has had widespread use since its introduction because it is brief and
has strong psychometric properties, including evidence for validity (Jerome & Gross, 1991; Tait,
Chibnall, & Krause, 1990; Tait, Pollard, Margolis, Duckro, & Krause, 1987), reliability
(Gronblad et al., 1993), and sensitivity to change (Strong, Ashton, & Large, 1994). The PDI was
introduced to the psychological practice in 2004 and only 241 patients included in this study
have PDI scores.

Analysis Strategy
Using three different methods, exploratory two-step cluster analyses1 were conducted to
group the participants. The two-step cluster analysis was selected as the clustering method
because is often the method preferred for large data sets as hierarchical clustering do not scale
efficiently when number of subjects is very large e.g. n > 200 (Milligan& Hirtle, 2003).
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Method 1. (the traditional clustering method) used the MMPI-2 standard clinical scales
and the traditional validity scales L, F and K. to test whether the previously found pain subgroups
are also found in the present medico-legal sample.
Method 2. (the MMPI-2 clustering method) used all the MMPI-2 standard clinical scales
and all the validity scales including L, F, K, Fb, Fp and FBS to test whether the inclusion of the
over reporting validity scales in the cluster analysis impact the number and the characteristics of
pain subgroups in the current medico-legal sample (the MMPI-2 clustering method).
Method 3. (the MMPI-2-RF clustering method) used the MMPI-2-RF RCd- RC9 and RF
validity scales to test whether a cluster analysis using the newly developed MMPI-2-RF scales
influence the previously found MMPI-2 cluster number and characteristics.
For each method, it was determined the best cluster solution (number of clusters) from
the autoclustering technique of the Statistical Package for the Social Sciences- 14th edition (SPSS
14). Then, Multivariate Analysis of Variance (MANOVA), Analysis of Variance (ANOVA) or
Chi squared analysis were conducted, where appropriate, to determined differences between the
resulted subgroups in several important variables: MMPI-2, MMPI-2-RF, demographics, injury
severity, legal status, malingering status, pain perception and predictors of poor outcome.

1

End Notes
Two-step cluster analysis is often preferred Clustering method for large datasets, since

hierarchical and k-means clustering do not scale efficiently when n is very large
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CHAPTER V
RESULTS
Preliminary Analyses
Before running the cluster analyses, assumptions of normality and independence of
variables were evaluated. The distributions presented in Table 5 indicated that all MMPI-2 and
MMPI-2-RF variables were relatively normally distributed (Skewness and Kurtosis < + or -2.0;
Shapiro & Wilk, 1965). However, FBS demonstrated an elevated Kurtosis statistic of 2.66.
Results also indicated that most MMPI-2 variables meet the assumption of independence of
variables (r < .80; Tabachnick & Fidell, 2001). However, there was high multicollinearity
between scales Fb and 8 (r = .81) and between scales 7 and 8 (r = .85).
All the MMPI-2-RF scales showed low to medium correlations between each other,
meeting the assumption of independence of variables (r < .80; Tabachnick & Fidell, 2001).
Therefore, the assumptions of normality and independence of variance were not fully met for all
the MMPI-2 variables; these assumptions were met for the MMPI-2-RF variables. Despite the
MMPI-2 results, all the proposed cluster analyses were performed because the two-step cluster
analysis is fairly robust even when the normality and independence of variables assumptions are
violated (Milligan& Hirtle, 2003).
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Table 5
Normality statistics for the MMPI-2 and MMPI-2-RF variables
Skewness

Kurtosis

MMPI-2 Scales

Statistic

Standard Error

Statistic

Standard Error

L

0.54

0.10

0.39

0.20

F

0.98

0.10

0.55

0.20

Fb

0.33

0.10

-0.73

0.20

Fp

0.66

0.10

-0.75

0.20

FBS

1.48

0.10

2.66

0.20

K

-0.04

0.10

-0.46

0.20

1

-0.10

0.10

-0.21

0.20

2

-0.38

0.10

-0.41

0.20

3

-0.05

0.10

-0.25

0.20

4

0.28

0.10

-0.41

0.20

5

0.21

0.10

0.04

0.20

6

0.51

0.10

-0.17

0.20

7

-0.02

0.10

-0.47

0.20

8

0.34

0.10

-0.43

0.20

9

0.71

0.10

0.12

0.20

0

0.19

0.10

-0.70

0.20

MMPI-2-RF Scales
L-r
F-r
Fp-r
Fs
FBS-r
K-r
RCd
RC1

0.31
1.29
0.56
0.02
0.31
0.29
-0.35
0.09

0.11
0.11
0.11
0.11
0.11
0.11
0.11
0.11

-1.12
1.69
-0.54
-0.68
-0.20
-0.65
-0.74
-0.84

0.23
0.23
0.23
0.23
0.23
0.23
0.23
0.23

RC2

0.13

0.11

-0.73

0.23
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Table 5 Cont.
RC3
RC4
RC6
RC7
RC8
RC9

0.34
0.59
0.88
0.27
0.58
0.72

0.11
0.11
0.11
0.11
0.11
0.11

-0.88
-0.25
0.25
-0.79
-0.24
0.99

0.23
0.23
0.23
0.23
0.23
0.23

Note. F: Infrequency; Fb: Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom
Validity scale; L: Lie; K: Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4:
Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 :
Hypomania; 0 : Social Introversion. . F-r: Infrequency restructured; Fp-r: Infrequency psychopathology
restructured; Fs: Infrequency somatic symptoms; FBS-r: Symptom Validity scale restructured; L: Lie
restructured; K: Correction restructured; scales RCd-RC9: RCd: Demoralization; RC1: Somatic
Complains; RC2: Low Positive Emtions; RC3: Cynism; RC4: Antisocial Behavior; RC6: Ideas of
Persecution;RC7: Dysfunctional Negative Emotions; RC8: Aberrant Experiences; RC9: Hypomanic
Activation.

Method 1: Traditional Clustering Method
Defining the Number of Clusters
In Method 1 an exploratory two-step cluster analysis was conducted using the MMPI-2
traditional validity scales L, F and K and the ten clinical scales. As mentioned above, the
autoclustering selection from SPSS 14 was used to select the best cluster solution. As a rule of
thumb, the SPSS autoclustering will select as the best solution the one with the lowest
information criterion measure (the Schwarz Bayesian Information Criterion; BIC) and the
highest ratio of distance measures (RDM; “SPSS 14”, 2005).
Because autoclustering solution is affected by order of the data (Milligan& Hirtle, 2003),
first, autoclustering was conducted on the full data set ordering the data ascendingly by patient’s
ID number. Results showed that the optimal number of clusters was the two cluster solution. In
support of the two-cluster solution, there was dramatic jump in variance explained from the one
(BIC = 5412.4) to two (BIC = 4422.7; RDM = 2.8) cluster solution with only modest increases
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when three (BIC = 4170.0; RDM = 2.1) and four clusters (BIC =4098.7, RDM = 1.4) solutions
were isolated.
Then, full data set was sorted descendingly by patient’s ID number. This time it was
determined that the optimal number of clusters was the three-cluster solution. In support of the
three-cluster solution, there was dramatic jump in variance explained from one (BIC = 5007) to
two (BIC = 4525.6; RDM = 2.2) cluster solution and a similar jump from two to three (BIC =
4202.7, RDM = 2.0) cluster solution with only a modest decrease when four (BIC = 4127.2;
RDM = 1.7) and five clusters (BIC =4135.5; RDM = 1.1) solutions were isolated.
Selection of Best Cluster Solution
To select the “best” cluster solution, 50 cluster analyses were all run after randomly
sorting the data set using 70% of the total sample. Out of the 50 runs, autoclustering determined
that the two-cluster solution was more adequate 33 times (66 %) while the three-cluster solution
was the most adequate 10 times (20%) and a four-cluster solution was most adequate 7 times
(14%). Results using Binomial Tests demonstrated significant differences between observed
proportion and the expected proportion between the appearance of the two and three-cluster
solution and the two and four-cluster solutions (p< .001). Thus, the two-cluster solution was
considered the most adequate number of groups for Method 1. The two-cluster solution was
composed by a group with 342 participants and a group with 267 participants and these were
further described in a number of MMPI, non-MMPI, pain perception and predictor of outcome
variables.
Characterization of Pain Clusters based on all MMPI Variables
MMPI-2 Variables. First, the two subgroups were described and compared on all available
MMPI-2 variables, this included the over reporting scales Fb, Fp and FBS even when these were
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not used to determine the groups. Multivariate Analysis of Variance (MANOVA) demonstrated
overall differences in MMPI-2 variables between the two groups [Wilk’s Lambda; F (16, 564) =
10784.0, p<.001, Eta2=.99]. Subsequent Analysis of Variance (ANOVA) and Tukey’s b post hoc
analyses demonstrated significant differences between the two groups in all the MMPI-2
variables. Table 6 presents means and standard deviations for all MMPI-2 scales by each
subgroup. Figure 5 illustrates the profiles of the two subgroups based on the variables used to
create the clusters. As can be seen in Figure 5, one subgroup had no elevated validity scales and
three scales (scales 1, 2 and 3) with very high mean scores (this group was called Method 1Triad). The second group, on the other hand, had two mean scores (scales F and FBS) in the may
be exaggerated range, one score (scale Fb), in the may be invalid range, two scales (scales 4 and
0) with high mean scores, and six scales (scales 1, 2, 3, 6, 7 and 8) with very high mean scores
(this subgroup was called Method 1-Pathological).
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Table 6
Method 1 MMPI-2 mean, standard deviations, and statistical differences by subgroup

L
F
Fb
Fp
FBS
K
1
2
3
4
5
6
7
8
9
0

M1Triad
M(sd)
63.0(11.7)
55.3(8.9)
55.6(8.9)
51.4(9.7)
75.9(13.6)
53.9(10.5)
79.0(10.4)
75.6(12.6)
81.4(15.3)
58.6(10.1)
49.3(10.1)
56.0(11.9)
63.9(11.3)
64.5(9.9)
50.2(9.2)
52.8(8.6)

M1Pathological
M(sd)
57.4 (10.2)
82.0 (16.9)
91.9 (19.2)
64.0(15.9)
90.7(12.0)
41.4(7.9)
86.2(8.5)
90.0(9.5)
87.7(12.9)
70.6(11.8)
51.6(8.1)
82.2(15.3)
85.7(10.1)
91.0(12.2)
57.2(11.5)
69.2(9.4)

F
35.6
604.2
744.5
140.4
185.6
248.3
77.8
234.5
27.6
174.8
8.7
539.3
575.5
831.7
64.8
479.9

p<
.001
.001
.001
.001
.001
.001
.001
.001
.001
.001
.003
.001
.001
.001
.001
.001

Eta2
0.06
0.51
0.56
0.20
0.24
0.30
0.12
0.29
0.05
0.23
0.02
0.48
0.49
0.59
0.10
0.46

Note. M1-Triad: M1 subgroup with a Triad profile; Method 1-Pathological : Method 1subgroup with a
Pathological profile; F: Infrequency; Fb: Infrequency back; Fp: Infrequency psychopathology; FBS:
Symptom Validity scale; L: Lie; K: Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3:
Hysteria; 4: Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8:
Schizophrenia; 9 : Hypomania; 0 : Social Introversion.
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Figure 5. Method 1 illustration of the profiles of the two subgroups described by all the
MMPI-2 scales

Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a
Pathological profile; F: Infrequency; Fb: Infrequency back; Fp: Infrequency psychopathology; FBS:
Symptom Validity scale; L: Lie; K: Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3:
Hysteria; 4: Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8:
Schizophrenia; 9 : Hypomania; 0 : Social Introversion.

The number of patients that scored at or above the selected scores was also different
between the two groups. As can be seen in Table 7, the Method 1-Pathological subgroup had
significantly more patients scoring at the may be exaggerated and maybe invalid ranges than
Method 1-Triad subgroup; exceptions were scales L and K where the Method 1-Triad had more
patients than the Method 1-Pathological at those ranges. Method 1-Triad and Method 1Pathological subgroups had similar number of patients with high mean scores on scales 1, 2, and
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3. However, the Method 1-Pathological had a higher percentage of patients than Method 1-Triad
with very high mean scores on the same scales. The most noticeable differences in the clinical
scales were in scales 4, 6, 7, 8 and 0 where the Method 1-Pathological had at least four times
more patients than the Method 1-Triad with very high mean scores.
Table 7
Method 1 percentage of cases that fall above the interpretative cutoff per MMPI-2 variable
Maybe exaggerated
Maybe invalid
Scale
M1-Triad
M1-Pathological
M1-Triad
M1-Pathological
F
Fb
Fp
FBS
L
K

1
2
3
4
5
6
7
8
9
0

7
4
5
41
47
15

77
67
35
85
28
2

0
2
0
6
8
2

High scores
M1-Triad
M1-Pathological
94
97
78
100
85
96
28
68
8
6
23
86
47
99
53
99
10
27
10
69

28
55
4
23
2
0

Very high scores
M1-Triad
M1-Pathological
68
90
54
96
67
83
6
37
1
0
7
67
18
87
16
93
2
9
1
25

Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a
Pathological profile; F: Infrequency; Fb: Infrequency back; Fp: Infrequency psychopathology; FBS:
Symptom Validity scale; L: Lie; K: Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3:
Hysteria; 4: Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8:
Schizophrenia; 9 : Hypomania; 0 : Social Introversion.

MMPI-2-RF Variables. The two subgroups were also characterized using all MMPI-2-RF
scales. This was done to determine similarities and differences between the two MMPI versions
when testing pain patient subgroups. MANOVA demonstrated overall differences in MMPI-2RF mean scores between the two groups [Wilk’s Lambda; F (15, 434) =18428.8, p<.001,
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Eta2=1.00]. Subsequent ANOVA and Tukey’s b post hoc analyses demonstrated that there were
significant differences between the groups in all the MMPI-2-RF variables. Table 8 presents
scales mean and standard deviations for each group. Figure 6 illustrates the two subgroups based
on MMPI-2-RF variables. Table 8 and Figure 6 show that the M1-Triad has no elevated validity
scales and only one scale with very high mean score (RC1). The M1-Pathological, on the other
hand, had two mean scores in the may be exaggerated range (scales Fs and FBS-r), one score in
the may be invalid range (scale F-r), four high mean scores (RCd, RC2, RC6, RC7, RC8), and
one very high mean score (scale RC1).
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Table 8
Method 1 MMPI-2-RF mean, standard deviations, and statistical differences by subgroup.
M1-Triad
M(sd)

M1-Pathological
M(sd)

L-r

62.9 (12.2)

F-r

F

p<

Eta2

60.1 (11.6)

6.1

.014

0.01

66.4(12.0)

102.5 (15.8)

458.5

.001

0.63

Fp-r

51.0(8.9)

70.7(17.5)

239.5

.001

0.35

Fs

60.3(14.6)

83.9(19.1)

219.5

.001

0.33

FBS-r

71.8(13.4)

88.1(12.1)

180.0

.001

0.29

K-r

49.6(9.9)

37.9(7.5)

192.5

.001

0.30

RCd

56.6(9.8)

74.8(7.1)

488.1

.001

0.52

RC1

71.6(9.8)

85.3(9.5)

223.4

.001

0.33

RC2

61.9(11.2)

75.9(12.1)

158.1

.001

0.26

RC3

50.0(12.3)

54.5(12.1)

67.5

.001

0.13

RC4

46.1(50.6)

56.2(11.8)

61.4

.001

0.12

RC6

53.1(9.9)

73.3(116.6)

279.6

.001

0.38

RC7

48.4(9.2)

68.6(10.8)

461.1

.001

0.51

RC8

50.8(9.2)

69.5(13.9)

292.8

.001

0.40

RC9

42.7(9.2)

49.6(9.5)

57.2

.001

0.11

Note M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a
Pathological profile; . F-r: Infrequency restructured; Fp-r: Infrequency psychopathology restructured; Fs:
Infrequency somatic symptoms; FBS-r: Symptom Validity scale restructured; L: Lie restructured; K:
Correction restructured; scales RCd-RC9: RCd: Demoralization; RC1: Somatic Complains; RC2: Low
Positive Emtions; RC3: Cynism; RC4: Antisocial Behavior; RC6: Ideas of Persecution;RC7:
Dysfunctional Negative Emotions; RC8: Aberrant Experiences; RC9: Hypomanic Activation.
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Figure 6. Method 1 illustration of the profiles of the two subgroups described by all the
MMPI-2-RF scales.

Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological: Method 1subgroup with a
Pathological profile; . F-r: Infrequency restructured; Fp-r: Infrequency psychopathology restructured; Fs:
Infrequency somatic symptoms; FBS-r: Symptom Validity scale restructured; L: Lie restructured; K:
Correction restructured; scales RCd-RC9: RCd: Demoralization; RC1: Somatic Complains; RC2: Low
Positive Emtions; RC3: Cynism; RC4: Antisocial Behavior; RC6: Ideas of Persecution;RC7:
Dysfunctional Negative Emotions; RC8: Aberrant Experiences; RC9: Hypomanic Activation.

In addition, as can be seen in Table 9, the Method 1-Pathological had at least ten times
more patients scoring at the may be exaggerated and maybe invalid ranges than the Method 1Triad on the over-reporting validity scales. Method 1-Triad and Method 1-Pathological had
similar number of patients with high mean scores on scale RC1. However, the Method 1Pathological had noticeably more patients than the Method 1-Triad with very high mean scores
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on the same scale. The most visible differences between the groups were in scales RCd, RC6,
RC7, and RC8 where Method 1-Triad had about 10% of patients scoring at the high scores range
while the Method 1-Pathological had more than 60% of patients scoring at the same range.
Table 9
Method 1 percentage of Cases that fall above the selected cutoff per MMPI-RF variable
May be exaggerated
May be invalid
M1
M1M1M1Scale
-Triad
Pathological
Triad
Pathological
F-r
3
70
0
61
Fp-r
1
26
0
13
Fs
13
58
6
44
FBS-r
32
81
8
42
L-r
30
23
12
6
K-r
7
0
0
0
High scores
Very high scores
M1M1M1M1Triad
Pathological
Triad
Pathological
RCd
24
91
0
31
RC1
79
99
20
72
RC2
45
83
9
43
RC3
14
42
2
3
RC4
8
24
0
2
RC6
15
70
1
34
RC7
6
65
0
20
RC8
7
62
0
22
RC9
3
7
0
1
Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a
Pathological profile; F-r: Infrequency restructured; Fp-r: Infrequency psychopathology restructured; Fs:
Infrequency somatic symptoms; FBS-r: Symptom Validity scale restructured; L: Lie restructured; K:
Correction restructured; scales RCd-RC9: RCd: Demoralization; RC1: Somatic Complains; RC2: Low
Positive Emtions; RC3: Cynism; RC4: Antisocial Behavior; RC6: Ideas of Persecution;RC7:
Dysfunctional Negative Emotions; RC8: Aberrant Experiences; RC9: Hypomanic Activation.

Non-MMPI Characteristics of Pain Clusters
Demographics. Differences between the two resulted groups in demographic report were
tested using ANOVA or Chi squared analysis where appropriate. Table 10 presents demographic
data by group. The Method 1-Triad patients were significantly shorter post- injury and had a
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higher education than those in the Method 1-Pathological subgroup. Method 1-Pathological
subgroup also had less number of male participants and Caucasians. Indeed, odd ratios analysis
indicated that the Method 1-Pathological subgroup was 1.4 times (95% C.I. = 1.3-1.5) less likely
to be male and 2.0 times (95% C.I. = 1.5-1.3) less likely to be Caucasian than the Method 1Triad subgroup.
Table 10
Method 1 demographic characteristics by subgroup

Age
Education
Time since Injury
Gender (male)
Race (white)

M1Triad
M(sd)
42.6 (8.9)
12.0(2.5)
35.7(27.7)
(%)
68.9
72.6

M1Pathological
M(sd)
42.5(8.5)
11.5(2.4)
41.8(30.8)
(%)
60.2
57.0

F

p≤

Eta2

0.2
6.7
3.2
X2
4.7
20.4

NS
.012
.013
p≤
.031
.001

0.00
0.11
0.00

Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a
Pathological profile

Injury Severity. Univariate ANOVA demonstrated that there are not differences in the Injury
Severity scale between Method 1-Triad (M = .79; sd = 1.2) and Method 1-Pathological (M = .81;
sd = 1.1) [F (1, 583) = 0.06, p > .05, Eta2=0.01]. Table 11 presents the injury and symptom
characteristics of the sample as a function of group membership. Differences between the two
groups in injury/symptom characteristics were also tested using Chi squared analysis. As can be
seen, groups did not differ in injury type, location, or etiology.
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Table 11
Method 1 percentage of patients with specific Injury/Symptom characteristics by pain group

Primary back/spine injury
Head injury in accident
Other Pain symptoms / area of body
Head
Chest / abdomen
Upper extremity
Lower extremity
Spine Findings
any spine findings
degenerative disc/spine
herniated nucleus pulposus
disc bulge/protrusion
neural impingement
Spinal Surgery
discectomy / fusion
decompression/laminectomy
Other pain diagnoses
Complex regional pain syndrome
Fibromyalgia
Myofascial pain syndrome

M1-Triad
91.6
8.3

M1-Pathological
88.9
8.0

X2
1.8
3.9

p<
NS
NS

23.9
5.0
42.2
69.4

30.2
9.3
42.0
66.0

4.3
3.7
1.3
0.5

NS
NS
NS
NS

40.0
20.0
5.6
26.7
2.8

36.4
21.6
5.6
22.8
3.1

0.5
0.3
0.6
0.8
1.7

NS
NS
NS
NS
NS

26.7
11.7

30.9
17.9

3.2
2.8

NS
NS

2.8
2.8
1.7

3.7
3.1
6.2

1.0
0.9
4.7

NS
NS
NS

Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a
Pathological profile

Legal Status. Differences between the two subgroups in legal characteristics were tested
using Chi squared analysis. Table 12 presents the legal status of the sample as a function of
group membership. Groups did not differ in the status of legal representation, referral source or
type of legal claim.
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Table 12
Method 1 medico-legal characteristics of the chronic pain sample as a function of group
membership.

Status of legal representation
No Attorney
Represented by attorney
Attorney status unknown
Referral source
doctor
case manager / adjuster
attorney
district attorney
Claim type
workers compensation
personal injury
disability

M1-Triad
%

M1-Pathological
%

29.8
57.4
15.5

X2

p=

27.1
55.7
14.5

0.55

NS

28.0
49.8
4.4
18.3

27.1
47.9
3.6
19.9

0.66

NS

87.3
11.6

81.9
17.2

3.60

NS

0.8

0.6

Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a
Pathological profile

Malingering Diagnosis. Differences between the two subgroups in MPRDa and MPRDb
diagnosis were also tested using Chi squared analysis. Table 13 presents the malingering
diagnosis of the sample as a function of group membership. The two subgroups differed
significantly in MPRD status: MPRDa [Χ2 (4,583) = 104.5, p< .001].Odd ratios analysis
indicated that the Method 1-Pathological was 10.5 times (95% C.I. = 10.6-10.5) more likely to
be MPRD than Method 1-Triad subgroup when not using the MMPI variables as malingering
indicators. When the MMPI variables were included as indicators the odds ratio increased to 27.8
(95% CI = 27.8- 27.5).
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Table 13
Method 1Malingering status by pain group
Method 1 MPRDa status by subgroup
M1Triad
%
43.4
26.5
15.4
4.8
20.2

M1Pathological
%
14.2
33.9
39.8
12.0
51.8

M1-Triad
%
42.2
32.8
20.2
4.8
25.0

M1-Pathological
%
3.6
31.1
53.4
12.0
65.4

Not MPRD
Possible MPRD
Probable MPRD
Define MPRD
All MPRD

X2

p<

104.5

.001

X2

p<

138.9

.001

Method 1 MPRDb status by subgroup

Not MPRD
Possible MPRD
Probable MPRD
Define MPRD
All MPRD

Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a
Pathological profile MPRDa: Malingered Pain Related Disability not including the MMPI-2 variables;
MMPIb: Malingered Pain Related Disability including the MMPI-2 variables

Pain Report and Predictors of Outcome. Finally, to determine differences in pain report and
predictors of outcome, pain reports, levels catastrophization and functional capacity were
compared among the two subgroups. Differences between the two groups in pain report, PCS
and PDI scores were tested using ANOVA. Pain reports were available for all patients. PCS
scores were available for 72 participants from the Method 1-Triad subgroup and for 68
participants from the Method 1-Pathological subgroup. PDI data was available for 118
participants from the M1-Triad subgroup and 95 participants from the M1-Pathological
subgroup. Table 14 presents data for these variables by group. Results showed that the Method 1Pathological reported significantly higher levels of “best” pain, catastrophization and perceived
disability than those in the Method 1-Triad.
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Table 14
Method 1 current, best, worst pain report, PCS and PDI scores as a function of pain group

Current Pain
Best Pain
Worst Pain
PCS

M1-Triad
M(sd)
6.4(2.0)
4.6(2.1)
9.2(1.5)
69.3(14.5)

M1-Pathological
M(sd)
6.7(1.8)
5.1(2.2)
9.2(1.3)
80.9(13.3)

F
2.2
4.7
0.1
24.2

p<
NS
.032
NS
.001

Eta2
0.10
0.10
0.00
0.15

48.6(13.1)
55.5(10.0)
17.4
.001
0.08
PDI
Note. M1-Triad: Method 1 subgroup with a Triad profile; M1-Pathological : Method 1subgroup with a
Pathological profile.

Method 1 Summary and Conclusions
After conducting several exploratory two step cluster analyses using the MMPI-2
traditional validity scales L, F and K and the 10 clinical scales it was determined that the best
solution was the two-cluster solution because it was picked by SPSS autoclustering significantly
more frequently as the best solution than the other solutions. The two-cluster solution was
characterized by two homogeneous groups that differed drastically in the number and type of
MMPI-2 scales elevated as well as the number of patients with elevations. The first subgroup
elevated only on scales 1, 2 and 3; thus it was called Method 1-Triad. The second subgroup had
elevations on scales F, 1,2,3,4,6,7,8 and 0 and it was called Method 1-Pathological. Note that the
scores on scales 1, 2 and 3 were significantly higher in the Method 1-Pathological than the
Method 1-Triad subgroup.
Differences between the subgroups were seen also in scales Fb, Fp and FBS although
these scales were not used as variables to create the groups. This suggests that the new overreporting scales not only have an important relationship with the other scales (e.g., scale F) but
also present important information regarding the validity of the symptom presentation by patients
in the Method 1-Pathological subgroup. Moreover, the two determined pain subgroups differed
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on the MMPI-2-RF scales. Like the MMPI-2, the Method 1-Pathological reported higher mean
score and a larger number MMPI-2-RF scale scores than the Method 1-Triad. However, some
differences between the versions were observed. The Method 1-Triad had only one very high
mean score (RC1) on the MMPI-2-RF as opposed to three scales with very high scores (scales 1,
2, and 3) on the MMPI-2. This shows that there are differences in describing the same Method 1Triad profile when using the MMPI-2 and the MMPI-2-RF. Furthermore, while the Method 1Pathological demonstrated similar profiles between the MMPI test versions, on the MMPI-2-RF
two mean clinical scales were not elevated (RC3 and RC4) that were elevated on the MMPI-2.
Thus, the changes done for RC3 and RC4 (from scales 3 and 4) make the scales less sensitive to
report of pain symptoms related to the Method 1-Pathological profile.
When the groups were compared on demographic, injury/symptom characteristics, legal
status and malingering diagnosis, differences were found only on few variables. The Method 1Pathological was less educated, had more time post- injury, had less Caucasians, less males, and
more malingerers than the Method 1-Triad. In fact, Method 1-Pathological patients were 10 to
28 times more likely to be diagnosed as malingerers than the Method 1-Triad patients. These
results reveal that group membership was not conditioned to injury/ symptom severity or legal
status. Instead, group membership was related to some demographic characteristics and
malingering diagnosis. Finally, best pain report levels, level of catastrophization and perceived
disabilities were significantly higher for the Method 1-Pathological than the Method 1-Triad.
These results support the idea that those with Method 1-Pathological profiles are more likely to
have poorer outcome than Method 1-Triad profiles.
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Method 2: MMPI-2 Clustering Method
Defining the Number of Clusters
In Method 2, an exploratory two step cluster analysis was conducted using the MMPI-2
validity scales F, Fb, Fp, FBS, L and K and the ten clinical scales. As done in Method 1, SPSS
autoclustering was used to determine the best cluster solution. Again, the full data set was first
ordered ascendingly by patient’s ID number when the autoclustering was performed. It was
determined that the optimal number of clusters was the two-cluster solution. In support of the
two-cluster solution, there was a dramatic jump in variance explained from the one (BIC =
6639.2) to two (BIC = 5358.9; RDM = 2.4) cluster solution with only modest increases when
three (BIC = 5108.5; RDM = 1.9) and four-cluster (BIC =4977.9; RDM = 1.3) solutions were
isolated.
Then, the data was sorted ascendingly by ID and autoclustering determined that the threecluster solution was the optimal solution. In support of the three-cluster solution, there was a
dramatic jump in variance explained from one (BIC = 6639.17) to two (BIC = 5426.8; RDM =
1.9) and a greater dramatic jump from two to three (BIC = 4998.3; RDM = 2.4) cluster solution
with only modest increases when four (BIC = 4970.2; RDM = 2.1) and five cluster (BIC =5001.5;
RDM = 1.0) solutions were isolated.
Selection of Best Cluster Solution. To select the “best” cluster solution, 50 cluster analyses
were run after randomly resorting the data set using 70% of the total sample. Out of the 50 runs,
autoclustering determined that the two-cluster solution was most adequate 23 times (46 %), the
three-cluster solution was also the most adequate 23 times (46%) and a four-cluster solution was
most adequate only 4 times (8%). Results using Binomial Tests showed that there were no
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significant differences between observed proportion and the expected proportion between the
appearance of the two-cluster and three-cluster solutions (p > .05). The two-cluster and the threecluster solutions appeared significantly more times than the four-cluster solution (p< .001). This
suggests that the two-cluster solution and the three-cluster solution can be considered equally
adequate when using the all the validity MMPI-2 as a clustering method.
The two subgroups found in the two-cluster solution for Method 2 were: a group (Method
2- solution 2-A) with 323 participants and a group (Method 2- solution 2-B) with 258
participants. The three subgroups identified in the three-cluster solution were: a group (Method
2-solution 3-A) with 180 participants, a group (Method 2-solution 3-B) with 251 participants and
a group (Method 2-solution 3-C) with 150 participants. Using crosstab analysis it was determined
that all subjects classified in subgroup Method 2-solution 3-A were originally in subgroup
Method 2- solution 2-A. Similarly, all subjects classified as Method 2-solution 3-C were
originally in subgroup Method 2-solution 2-B. Subgroup Method 2-solution 3-B was composed
by 49% of subjects that were in subgroup Method 2-solution 2-A and 51% of subjects that were
in Method 2-solution 2-B.
Figure 7 presents the MMPI-2 profiles for the subgroups that resulted from the two-cluster
and the three-cluster solutions. As can be seen, when compared to the two-cluster solution, the
three-cluster solution presents Triad and Pathological profiles that differ substantially in the
elevation of scores. Moreover, the three-cluster profile demonstrated the existence of a Moderate
profile that is comprised of those patients that scored in the upper end of the two-cluster Triad
profile and those that scored in the lower end of the two-cluster Pathological profile.
Therefore, since the three-cluster solution provides 1) the most number of groups, 2)
information about a Moderate subgroup, and 3) creates larger separation between the Triad and
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Pathological profiles, the three-cluster solution was determined as the most comprehensive fit
for Method 2. As a result, the three subgroups that resulted from this solution were further
described using a number of MMPI, non-MMPI, pain perception and predictor of outcome
variables.
Figure 7. presents the MMPI-2 profiles for the subgroups that resulted from the two-cluster
and the three-cluster solutions

Note. F: Infrequency; Fb: Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom
Validity scale; L: Lie; K: Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4:
Psychopathic Deviate; 5: Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 :
Hypomania; 0 : Social Introversion.

Characterization of Pain Clusters based on all MMPI Variables
MMPI-2 Variables. As expected, MANOVA demonstrated overall differences in MMPI-2
mean scores between the three groups [Wilk’s Lambda; F(16, 563) = 13532.5, p<.001,
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Eta2=.99]. Subsequent ANOVA and Tukey’s b post hoc analyses demonstrated that there were
significant differences between the three subgroups on all the MMPI-2 variables. Table 15
presents scale means and standard deviations for each group. Figure 8 illustrates the subgroup
profiles.
As can be seen in Table 15 and Figure 8, the first subgroup (called above Method 2Solution 3-A) had no elevated validity scales, two scales (scales 2 and 3) with high mean scores
and one scale (scale 1) with a very high mean score; thus this group was referred Method 2Triad. The second subgroup (called above Method 2-Solution 3-B) had one mean score (FBS) in
the may be exaggerated range, one scale (scale 6) with a high mean score, and five scales (scales
1, 2, 3, 7 and 8) with high mean scores; this group was referred as Method 2-Moderate. Finally,
the last subgroup (called above Method 2-Solution 3-C) had three scores (scale F, Fb and FBS) in
the may be invalid range, two high mean scores (scales 4 and 0), and six scales (scales 1, 2, 3, 6,
7 and 8) with high mean scores; this group was referred as Method 2-Pathological).
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Table 15
Method 2 MMPI-2 scales means and standard deviations by group
M2M2M2Triad
Moderate
Pathological
M(sd)
M(sd)
M(sd)
a
b
L
63.6(12.4)
60.4(10.7)
57.3 (10.5)c
51.9(8.0)a
63.7(10.8)b
89.7(15.9)c
F
Fb
50.7(8.0)a
63.7(10.8)b
89.7(15.9)c
Fp
51.2(10.8)a
53.5(9.4)a
69.0(17.0)b
FBS
68.0(9.7)a
85.5(11.5)b
93.8(11.4)c
K
55.7(10.6)a
48.7(10.3)b
39.6(6.9)c
1
74.6(8.3)a
84.1(9.4)b
87.9(8.2)c
2
67.6(9.2)a
86.0(8.8)b
91.7(9.2)c
88.9(14.5)b
88.5(11.6)b
3
73.7(11.4)a
64.4(11.0)b
73.1(11.0)c
4
55.0(8.7)a
5
49.2(11.0)a
50.0(8.7)a
52.2(7.9)b
66.3(11.4)b
89.3(13.7)c
6
50.1(9.5)a
7
56.7(8.5)a
75.7(8.6)b
89.2(9.9)c
8
58.8(8.3)a
75.0(8.5)b
97.7(75.8)c
9
50.1(9.2)a
52.0(10.5)a
58.8(11.2)b
0
49.9(8.0)a
59.7(9.6)b
71.8(8.4)c

F
12.8
445.8
632.8
103.5
247.2
114.7
105.5
339.9
85.6
126.2
4.6
475.3
557.7
796.4
32.0
251.5

p≤
.001
.001
.001
.001
.001
.001
.001
.001
.001
.001
.011
.001
.001
.001
.001
.001

Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile; F: Infrequency; Fb:
Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom Validity scale; L: Lie; K:
Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4: Psychopathic Deviate; 5:
Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social
Introversion
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Eta2
0.04
0.61
0.69
0.26
0.46
0.28
0.27
0.54
0.23
0.30
0.02
0.63
0.66
0.73
0.10
0.47

Figure 8 illustrates the subgroup profiles for the Method 2 most comprehensive solution
by MMPI-2 scales

Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile; F: Infrequency; Fb:
Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom Validity scale; L: Lie; K:
Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4: Psychopathic Deviate; 5:
Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social
Introversion

The number of patients that scored at or above the interpretative cutoffs was also
different between the three groups. As can be seen in Table 16, the Method 2-Pathological had
considerably more patients scoring at the may be exaggerated and maybe invalid ranges than the
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Method 2-Triad and the Method 2-Moderate. The Method 2-Moderate had consistently more
patients with elevated scores than the Method 2-Triad in all over-reporting scales, especially on
FBS. However, on scales L and K, the Method 2-Triad had more patients with elevated scores
than the other subgroups. All subgroups had similar number of patients with high mean scores on
scales 1, 2, and 3. However, the Method 2-Moderate and the Method 2-Pathological had more
patients than the Method 2-Triad with very high mean scores on the same scales. The most
noticeable differences in the clinical scales were in scales 6, 7 and 8 where the Method 2-Triad
had less than 5%, the Method 2-Moderate had about 50%, and the Method 2-Pathological had
more than 85% of patients with very high mean scores.
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Table 16
Method 2 percentage of cases that fall above the selected cutoff per subgroup and MMPI-2 variable
M2Triad
Scale
F
Fb
Fp
FBS
L
K

3
1
7
13
48
-

1
2
3
4
5
6
7
8
9
0

M2Triad
91
60
77
16
28
5
16
27
11
4

Maybe exaggerated
M2M2Moderate
Pathological
28
92
17
91
8
47
73
93
38
29
High Scores
M2M2Moderate
Pathological
99
99
99
99
94
96
48
76
32
37
55
97
90
99
90
100
14
31
31
79

M2Triad
0
0
0
0
10
18
M2Triad
54
25
48
1
2
2
1
2
1
1

Maybe invalid
M2M2Moderate
Pathological
2
43
8
81
0
5
13
33
4
3
7
0
Very High Scores
M2M2Moderate
Pathological
86
93
91
96
82
87
16
46
0
1
24
85
53
93
52
100
4
11
8
37

Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile; F: Infrequency; Fb:
Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom Validity scale; L: Lie; K:
Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4: Psychopathic Deviate; 5:
Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social
Introversion

MMPI-2-RF Variables. The three groups were also characterized using all the MMPI-2-RF
scales. Again, this was done to determine similarities and differences between the two MMPI
versions assessing MMPI-2 based groups. MANOVA demonstrated overall differences in
MMPI-2-RF mean scores between the three groups [Wilk’s Lambda; F(15, 431)=21374.5,
p<.001, Eta2=1.00]. Subsequent ANOVA and Tukey’s b post hoc analyses demonstrated that
there were significant differences between the groups on all the MMPI-2-RF variables. Table 17
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presents scale means and standard deviations for each group. Figure 9 illustrates the profiles of
the three subgroups based on all MMPI-2-RF variables.
Table 17 demonstrates that the Method 2-Triad had no elevated validity scales and only
one scale with high mean scores (scale RC1). The Method 2-Moderate, had one mean score in
the may be exaggerated range (FBS-r), two high mean scores (RCd and RC2), and one very high
mean score (RC1). Finally, the Method 2-Pathological had one scale in the may be exaggerated
range (Fs), two scores in the may be invalid range (F-r and FBS-r), four high mean scores (RCd,
RC2, RC7 and RC8), and two scales with very high mean scores (RC1 and RC6).
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Table 17
Method 2 MMPI-2-RF mean, standard deviations, and statistical differences by pain group

L-r
F-r
Fp-r
Fs
FBS-r
K-r
RCd
RC1
RC2
RC3
RC4
RC6

M2Triad
63.6 (12.9)a
60.1(8.9)a
50.1(9.1)a
54.8(11.2)a
64.1(9.6)a
51.9(10.2)a
50.7(7.8)a
66.6(6.7)a
56.0(8.8)a
40.7(12.5)a
46.9(10.0)a
51.3(10.4)a

M2Moderate
60.9(13.0)b
79.8(13.0)b
55.6(10.7)b
70.2(17.1)b
81.6(11.3)b
43.8(9.1)b
66.7(7.5)b
79.1(9.6)b
70.4(10.4)a
52.1(11.0)b
50.1(10.4)b
57.1(11.1)b

M2Pathological
60.3(11.7)b
112.0(9.7)c
77.1(17.7)c
89.9(17.1)c
91.7(11.4)c
36.7(7.1)c
77.6(5.8)c
88.0(8.7)c
77.9(11.9)b
61.6(11.8)c
56.7(12.1)c
80.1(15.8)c

F
3.0
723.0
165.5
164.4
217.7
92.9
459.3
204.9
149.9
33.9
27.5
195.5

p≤
.050
.001
.001
.001
.001
.001
.001
.001
.001
.001
.001
.001

Eta2
0.01
0.77
0.43
0.43
0.50
0.30
0.68
0.48
0.40
0.13
0.11
0.47

RC7

45.3(8.7)a

56.6(10.3)b

72.3(10.1)c

245.9

.001

0.53

RC8
RC9

a

b

c

217.2
27.2

.001
.001

0.50
0.11

48.7(8.7)
42.6(9.6)a

56.3(10.9)
44.7(9.6)a

75.4(12.0)
51.1(9.8)b

Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile . F-r: Infrequency
restructured; Fp-r: Infrequency psychopathology restructured; Fs: Infrequency somatic symptoms; FBS-r:
Symptom Validity scale restructured; L: Lie restructured; K: Correction restructured; scales RCd-RC9:
RCd: Demoralization; RC1: Somatic Complains; RC2: Low Positive Emtions; RC3: Cynism; RC4:
Antisocial Behavior; RC6: Ideas of Persecution;RC7: Dysfunctional Negative Emotions; RC8: Aberrant
Experiences; RC9: Hypomanic Activation.
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Figure 9. Method 2 illustration of the profiles of the three-cluster solution described by
theMMPI-2-RF scales

Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile; . F-r: Infrequency
restructured; Fp-r: Infrequency psychopathology restructured; Fs: Infrequency somatic symptoms; FBS-r:
Symptom Validity scale restructured; L: Lie restructured; K: Correction restructured; scales RCd-RC9:
RCd: Demoralization; RC1: Somatic Complains; RC2: Low Positive Emtions; RC3: Cynism; RC4:
Antisocial Behavior; RC6: Ideas of Persecution;RC7: Dysfunctional Negative Emotions; RC8: Aberrant
Experiences; RC9: Hypomanic Activation.

As can be seen in Table 18, the Method 2-Pathological had significantly more patients
scoring at the may be exaggerated and maybe invalid ranges than the Method 2-Moderate; and,
in turn, the Method 2-Moderate had more patients in the same ranges than the Method 2-Triad.
Exceptions were scales L-r, K-r where all groups had similar number of subjects with elevations.
Similarly, all groups differed in the RC scales. While 66% of patients in the Method 2-Triad
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scored high on RC1, the Method 2-Moderate and the Method 2-Pathological had more than 95%
of patients with high mean scores on the same scale. The Method 2-Moderate and the Method 2Pathological differences can be seen at higher RC1scores. The Method 2-Pathological had 85%
patients with very high mean scores while Method 2-Moderate had 46%. The most noticeable
differences between the groups in the RC scales were in RC7 and RC8, where the Method 2Triad had less than 5%, the Method 2-Moderate has about 20% and the Method 2-Pathological
has more than 75% of patients with high mean scores
Table 18
Method 2 percentage of cases that fall above the selected cutoff per group by MMPI-2-RF variable
May be exaggerated
May be invalid
M2M2M2M2M2M2Scale
Triad
Moderate Pathological
Triad
Moderate
Pathological
F-r
1
16
95
0
7
90
Fp-r
4
8
37
1
4
37
Fs
4
31
69
2
16
57
FBS-r
8
64
88
0
21
54
L-r
31
25
24
16
7
6
K-r
11
1
0
0
0
0
High scores
Very high scores
M2M2M2M2M2M2Triad
Moderate Pathological
Triad
Moderate
Pathological
RCd
3
63
96
0
4
47
RC1
66
96
99
4
46
85
RC2
22
75
85
1
22
53
RC3
20
20
51
0
1
3
RC4
7
11
30
0
1
2
RC6
16
27
85
2
3
51
RC7
4
23
77
0
2
30
RC8
2
22
80
0
3
33
RC9
3
4
8
1
0
2
Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile; . F-r: Infrequency
restructured; Fp-r: Infrequency psychopathology restructured; Fs: Infrequency somatic symptoms; FBS-r:
Symptom Validity scale restructured; L: Lie restructured; K: Correction restructured; scales RCd-RC9:
RCd: Demoralization; RC1: Somatic Complains; RC2: Low Positive Emtions; RC3: Cynism; RC4:
Antisocial Behavior; RC6: Ideas of Persecution;RC7: Dysfunctional Negative Emotions; RC8: Aberrant
Experiences; RC9: Hypomanic Activation.
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Non-MMPI Characteristics of Pain Clusters
Demographics. Differences between the three subgroups in demographics were tested using
ANOVA or Chi squared analysis where appropriate and Tukey’s post hoc analysis was
conducted when necessary. Table 19 presents demographic data by subgroup. The Method 2Triad patients were significantly more educated than the Method 2-Moderate and Method 2Pathological patients. The Method 2-Triad and Method 2-Moderate had more Caucasians than
the Method 2-Pathological. Subgroups did not differ in any other demographic variables. Odd
ratios analysis indicated that the Method 2-Pathological subgroup was 2.3 (95% C.I. = 2.4-2.3)
less likely to be Caucasian than the other subgroups.
Table 19
Method 2 demographic characteristics by pain group

Age
Education
Time since Injury
Gender (male)
Race (white)

M2Triad
M(sd)
42.5 (9.0)
12.3 (2.5)a
34.0 (27.9)
(%)
58.3
71.1a

M2Moderate
M(sd)
42.5 (8.8)
11.6 (2.4)b
40.7 (30.9)
(%)
65.3
70.9a

M2Pathological
M(sd)
42.4(8.2)
11.4 (2.5)b
39.5 (27.7)
(%)
68.7
51.3b

F

p≤

Eta2

0.1
6.4
2.9
X2
4.1
28.9

NS
.002
.055
p≤
NS
.001

0.00
0.02
0.01

Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile.
abc
row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test.

Injury Severity. ANOVA demonstrated that there were no differences in Injury Severity mean
scores between the Method 2-Triad (M = .82; sd = 1.1), M2-Moderate (M = .85; sd = 1.2), and
Method 2-Pathological (M = .72; sd = 1.1)[ F (1, 583) = 0.06, p > .05, Eta2=0.01]. Table 20
presents the injury and symptom characteristics of the sample as a function of group
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membership. Differences between the three subgroups in injury/symptom characteristics were
tested using Chi squared analysis. As can be seen, subgroups differed in the number of head pain
complaints. Method 2-Moderate had significantly more participants than Method 2-Triad and
Method 2-Pathological with head pain complains. Subgroups did not differ in other injury type,
location, or etiology variable.
Table 20
Method 2 percentage of patients with specific Injury/Symptom characteristics by pain group

Primary back/spine injury
Head injury in accident
Other Pain symptoms / area of
body
Head
Chest / abdomen
Upper extremity
Lower extremity
Spine Findings
any spine findings
degenerative disc/spine
herniated nucleus pulposus
disc bulge/protrusion
neural impingement
Spinal Surgery
discectomy / fusion
decompression/laminectomy
Other pain diagnoses
Complex regional pain syndrome
Fibromyalgia
Myofascial pain syndrome

M2Triad
91.6
9.4

M2Moderate
88.4
10.8

M2Pathological
87.3
10.7

X2

p<

1.8
0.2

NS
NS

23.3b
5.0
41.7
68.3

35.1a
6.4
39.8
70.5

27.3b
7.3
38.7
63.3

7.4
0.8
0.4
2.2

.025
NS
NS
NS

40.0
20.0
5.6
26.1
2.8

40.2
20.7
5.2
26.3
4.8

34.7
19.3
4.0
22.7
3.3

1.4
0.1
0.5
0.7
1.3

NS
NS
NS
NS
NS

26.1
11.7

35.5
15.1

30.7
20.0

4.2
4.4

NS
NS

2.2
2.8
1.7

2.4
2.0
3.6

4.0
2.7
6.7

1.2
0.3
5.7

NS
NS
NS

Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile.
abc
row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test.

Legal Status. Table 21 presents the legal status of the sample as a function of group
membership. Differences between the three subgroups in legal characteristics were tested using
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Chi squared analysis. Groups differed only in the type of legal claim. Method 2-Moderate had
less patients claiming workers compensation than the Method 2-Triad and Method 2Pathological. The Method 2-Triad and Method 2-Pathological did not differ on this variable.
Odds ratio analysis indicated that the Method 2-Moderate was 1.4 (95% CI = 1.4-1.3) and 3.3
(95% CI = 3.4-3.2) less likely to be involved in Workers Compensation than the Method 2-Triad
and Method 2-Pathological, respectively.
Table 21
Method 2 percentage of patients per group by legal status.

Status of legal
representation
No Attorney
Represented by
attorney
Attorney status
unknown
Referral source
doctor
case manager / adjuster
attorney
district attorney
Claim type
workers compensation
personal injury
disability

M2Triad
%

M2Moderate
%

M2Pathological
%

34.4

22.7

31.3

50.6

62.5

53.3

15.0

14.7

15.3

30.6
48.9
3.9
15.6

25.5
45.4
3.6
25.5

83.9 ab
14.4
0.6

X2

p=

8.6

NS

27.3
54.0
4.7
13.3

14.4

NS

79.3 b
19.9

92.7 a
6.7

16.3

.012

0.0

0.7

Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile.
abc
row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test.
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Malingering Diagnosis. Table 22 presents the malingering diagnosis of the sample as a
function of group membership. Differences between the three subgroups in malingering
diagnosis were tested using Chi squared analysis. The three subgroups differed significantly in
the status of the malingering diagnosis in MPRDa [X2(4,583) = 104.5, p< .001].More than half
(56-71%) of patients in the Method 2-Pathological were formally diagnosed as malingering
compared to 31-42 % patients in the Method 2-Moderate and 18% of Method 2-Triad patients.
Odd ratios analysis indicated that the Method 2-Pathological was 25.1 times (95% C.I. =
25.3-25.0) more likely to be MPRD than Method 2-Triad subgroup when not using the MMPI
variables as malingering indicators. Similarly, Method 2-Pathological was 8.1 times (95% C.I. =
8.2-7.9) more likely to be MPRD than Method 2-Moderate subgroup when not using the MMPI
variables as malingering indicators. The Method 2-Moderate was 3.1 times (95% C.I. = 8.2-7.9)
more likely to be MPRD than Method 2-Triad subgroup when not using the MMPI variables as
malingering indicators. When the MMPI variables were used as indicators the odd ratio to be
MPRD increased to 218.4 (95% C.I. = 219.5-217.4) for the Method 2-Pathological to the
Method 2-Triad, to 34.7 (95% C.I. = 35.7-33.6) for Method 2-Pathological to Method 2Moderate. The likelihood to be MPRD for the Method 2-Moderate increased to 6.3 (95% C.I. =
6.4-6.2) when compared to the Method 2-Triad.
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Table 22
Method 2 malingering status by pain group
Method 2 MPRDa status by subgroup
M2M2Triad
Moderate
%
%
a
58.9
35.5b
Not MPRD
23.3
32.7
Possible MPRD
13.3
25.9
Probable MPRD
4.4
6.0
Definite MPRD
17.7
31.9
All MPRD
Method 2 MPRDb status by subgroup
M2M2Triad
Moderate
%
%
a
b
54.0
19.2
Not MPRD
26.7
38.2
Possible MPRD
13.9
36.7
Probable MPRD
4.4
6.0
Definite MPRD
18.3
42.7
All MPRD

M2Pathological
%
11.3c
32.7
41.3
14.7
56.0
M2Pathological
%
1.0c
28.7
56.0
14.7
70.7

X2

p<

92.4

.001

X2

p<

163.7

.001

Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with
a Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile.
MPRDa: Malingered Pain Related Disability not including the MMPI-2 variables
MMPIb: Malingered Pain Related Disability including the MMPI-2 variables

Pain Report and Outcome. Differences in pain report and predictors of outcome were
determined by comparing current, best, and worst pain as well as catastrophization and
functional disability among the three subgroups. Differences between the three groups in pain
perception, PCS and PDI scores were tested using ANOVA. Pain perception data was available
for all patients. PCS scores were available for 38 participants from the Method 2-Triad subgroup,
59 participants from the Method 2-Moderate subgroup and for 41 participants from the Method
2-Pathological subgroup. PDI data was available for 61 participants from the Method 2-Triad
subgroup, 94 participants from the Method 2-Moderate subgroup and for 56 participants from the
Method 2-Pathological subgroup.
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Table 23 presents data for these variables by group. There was a significant group effect for
“current” pain rating with Method 2-Triad reporting less subjective least amount of pain than the
Method 2-Pathological. The Method 2-Moderate did not differ from the Method 2-Triad or the
Method 2-Pathological in current pain ratings. Moreover, results showed that those in Method 2Pathological had significantly higher mean scores than Method 2-Moderate, and Method 2Moderate had significantly higher mean scores than Method 2-Triad on the PC and PDI scales.
Table 23
Method 2 current, best and worst pain, PCS and PDI scores as a function of pain
group

Current Pain
Best Pain
Worst Pain
PCS
PDI

M2-Triad
M(sd)
6.2 (1.9)a
4.6 (2.0)
9.3 (1.1)
64.2(16.0)a
46.0(15.4)a

M2-Moderate
M(sd)
6.3 (1.9)ab
5.1 (2.2)
9.3 (1.3)
74.8(12.7)b
52.1(9.9)b

M2-Pathological
M(sd)
6.9 (2.0)b
5.4 (2.3)
9.1 (1.6)
84.6(10.2)c
61.6(8.9)c

F

P<

Eta2

3.5
2.9
0.2
24.2
13.5

.032
NS
NS
.001
.001

0.03
0.02
0.01
0.26
0.12

Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a
Moderate profile; M2-Pathological : Method 2subgroup with a Pathological profile.PCS = Pain
Catastrophizing Scale; PDI = Pain Disability Index
abc
row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test.

Method 2 Summary and Conclusions
After running several exploratory two-steps cluster analyses using the MMPI-2 scales F, Fb,
Fp, FBS, L and K and the ten clinical scales, two and three-cluster solutions were determined to
be appropriate solutions when using Method 2. Nevertheless, the three-cluster solution was
selected to be the “best” solution because it provided information over the two-cluster solution
and thus, it was further characterized.
The three-cluster solution was distinguished by three homogeneous subgroups that differed
considerably in the number and type of MMPI-2 scales elevated as well as the number of patients
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with scale elevations. Method 2-Triad elevated on scales 1, 2 and 3 and did not show overreporting of symptoms. Method 2-Moderate elevated on one validity scale (FBS) and six clinical
(scales 1, 2,3,6,7, and 8). Finally, Method 2-Pathological was characterized by mean elevations
on all over-reporting validity scales (i.e. F, Fp, Fb and FBS) and on eight out of the ten clinical
scales (i.e.1,2,3,4,6,7,8 and 0). Thus, when compared to Method 1, Method 2-Triad demonstrated
a lower profile (lower scores on the same elevated scales) than the Method 1-Triad; Method 2Pathological showed a higher profile (higher scores on the same elevated scales) than the
Method 1-Pathological; and there was the existence of a Method 2-Moderate subgroup that
likely comprise those patients that scored in the upper end of the two-cluster Method 1-Triad
profile and those that scored in the lower end of the two-cluster Method 1-Pathological profile.
Thus, in addition to the two profiles found with Method 1, using all MMPI-2 variables, as used
in Method 2, was able to consistently identify a new group (Method 2-Moderate) of patients that
reported moderate psychological difficulties.
When the three subgroups were compared on the MMPI-2-RF scales, these had similar
characteristics as the MMPI-2; that is, they differ in mean score and proportion of subjects with
elevated scales. However, MMPI-2-RF scales (RC3 and RC4) were less likely to be elevated by
the Method 2-Moderate and Method 2-Pathological even when they were elevated in the MMPI2. In fact, these were shown insensitive to “Moderate” profiles.
As Method 1, the three subgroups were also compared in demographic, pain report,
injury/symptom characteristics, legal status and malingering diagnosis. Differences were found
in education, current pain report, head complains, claim type and malingering diagnosis. Thus,
again, subgroup membership was not conditioned to the type/severity of the injury. Method 2Triad was described as a highly educated group, which reported low current pain. Method 2-
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Triad also had the lowest number of patients diagnosed as malingerers. Method 2-Moderate was
described as a low educated group, with the highest proportion of patients with head complains.
Method 2-Moderate had the higher number of patients with personal injury claims and these
patients were 3 times more likely to be diagnosed as malingerers than those in the Method 2Triad. Finally, Method 2-Pathological was described as low educated and diverse than the other
subgroups as it had the lowest grade completed and proportion of Caucasians. Finally, the
Method 2-Pathological was 25 and 8 times more likely to be diagnosed as malingering than the
Method 2-Triad and Method 2-Moderate respectively, when the MMPI variables were not used
as malingering indicators. The likelihood increased significantly when the MMPI variables were
used as indicators.
In terms of predictors of outcome, Method 2-Triad reported the lowest level of current
pain, catastrophization and perceived disability followed by Method 2-Moderate and then the
Method 2-Pathological. Thus, the results again supported the idea that MMPI-2 Triad profiles
tend to report better outcome than MMPI-2 Pathological profiles (as found in Part 1). Moreover,
it can be concluded that the new Moderate profile reports poor outcome levels but these levels
are lower than the Pathological profile.
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Method 3: MMPI-2-RF Clustering Method
Defining the Number of Clusters
Method 3 applied an exploratory two steps cluster analysis using the MMPI-2-RF validity
scales F-r, Fp-r, Fs, FBS-r, L-r and K-r and the nine RC scales. Again, SPSS autoclustering was
used to determine the best solution. Like the previous two methods the data was first ordered
ascendingly by patient’s ID number before running the autoclustering analysis. When the data
was ordered this way it was determined the optimal number of clusters was the two-cluster
solution. In support of the two-cluster solution, there was a dramatic jump in variance explained
from one (BIC = 4865.0) to two (BIC = 3901.6; RDM = 2.7) cluster solutions with only modest
increases when three (BIC = 3665.6; RDM = 1.6) and four-clusters (BIC =3578.8; RDM = 1.7)
solutions were isolated.
When sorting the full data set descendingly by patient’s ID number, it was determined
that the optimal number of clusters was the three-cluster solution. In support of the three cluster
solution, the BIC showed a dramatic jump in variance explained from one (BIC = 4865.0) to two
(BIC = 3846.9; RDM = 2.8) and a similar dramatic jump from two to three (BIC = 3594.0; RDM
= 2.4) cluster solution with only modest increases when four (BIC = 3595.6; RDM = 1.2) and
five clusters (BIC =3622.9; RDM = 1.0) solutions were isolated.
Selection of Best Cluster Solution. To select the “best” cluster solution, 50 cluster analyses
were all run after randomly resorting the data set using 70% of the total sample. Out of the 50
runs, BIC determined that the two cluster solution was the most adequate 25 times (50 %), the
three-cluster solution was the most adequate 23 times (46 %) and a four-cluster solution was
most adequate only 2 times (4 %). Results using Binomial Tests showed no significant
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differences between observed proportion and the expected proportion between the appearance of
the two and three solutions (p > .05). The two-cluster and the three-cluster solutions appeared
significantly more times than the four-cluster solution (p< .001). This suggests that the twocluster solution and the three-cluster solution are equally adequate for the current sample using
Method 3. As with Method 2, since the two and a the three-cluster solutions seemed to be
adequate, the three-cluster solution was selected as the “best fit” because it provides more
theoretical information over the two cluster-solution.
The two subgroups found in the two-cluster solution were: a group (Method 3-Solution 2-A)
with 277 participants and a group (Method 3- Solution 2-B) with 174 participants. The three
subgroups identified in the three-cluster solution were: a group (Method 3-Solution 3-A) with
143 participants, a group (Method 3-Solution 3-B) with 180 participants and a group (Method 3Solution 3-C) with 128 participants. Using crosstab analysis it was determined that all subjects
classified as in subgroups Method 3-Solution 3-A were originally in subgroup Method 3-Solution
2-A. Similarly, all subjects classified as Method 3-Solution 3-C were originally in subgroup
Method 3-Solution 2-B. Subgroup Method 3-Solution 3-B was composed by 74.4% of subjects
that were in subgroup Method 3-Solution 2-A and 25.6% of subjects that were in Method 3Solution 2-B.
Figure 10 presents the MMPI-2 profiles for the subgroups that resulted from the two-cluster
and the three-cluster solutions. As can be seen, when compared to the two-cluster solution, the
three-cluster solution presents Somatic and Pathological profiles that differ substantially in the
elevation of scores. Moreover, the three-cluster profile demonstrated the existence of a
Depressed subgroup due to its elevations on the demoralization, somatic and depressed scales in
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addition to FBS profile that is comprised of those patients that scored in the upper end of the
two-cluster Somatic.
Therefore, since the three-cluster solution provides 1) the most number of groups, 2)
information about a “Depressed” subgroup, and 3) creates larger separation between the Somatic
and Pathological profiles, it was determined the three-cluster solution was the most
comprehensive fit for Method 3. As a result, the three subgroups that resulted from this solution
were further described on a number of MMPI, non-MMPI, pain perception and predictor of
outcome variables.
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Figure10 presents the MMPI-2 profiles for the subgroups that resulted from the two-cluster
and the three-cluster solutions.

Note. F-r: Infrequency restructured; Fp-r: Infrequency psychopathology restructured; Fs: Infrequency
somatic symptoms; FBS-r: Symptom Validity scale restructured; L: Lie restructured; K: Correction
restructured; scales RCd-RC9: RCd: Demoralization; RC1: Somatic Complains; RC2: Low Positive
Emtions; RC3: Cynism; RC4: Antisocial Behavior; RC6: Ideas of Persecution;RC7: Dysfunctional
Negative Emotions; RC8: Aberrant Experiences; RC9: Hypomanic Activation.

Comparison of MMPI-2 and MMPI-2-RF Clustering Methods. Before, describing the
Method 3 subgroups, a crosstab comparison was performed between the MMPI-2 versus the
MMPI-2-RF methods used the in classification of pain patients into the subgroups. This was
done to understand the differences between the tests versions since it was determined that the
three-cluster solution was the most comprehensive fit for both methods. As can be seen in Table
24, 85% of the subjects who were classified as Method 3-Somatic were also classified as Method
2-Triad. Method 3-Depressed was composed of 77% of the subjects classified as Method 2-
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Moderate. Finally, Method 3-Pathological was composed of 88% of subjects that were classified
as Method 2-Pathological. This demonstrates that although there is an important overlap among
the classification methods, the methods did not agree for a range of 12-25% of the cases
depending on the subgroup profile.
Table 24
Crosstab on the percentage of cases that overlap between the clustering methods
Method 2
M2-Triad
M2-Moderate
M2-Pathological
%
%
%
85.2
14.8
0.0
M3-Somatic
Method 3 M3-Depressed
14.7
77.4
7.9
0.0
8.9
88.2
M3-Pathological
Note. M2-Triad: Method 2 subgroup with a Triad profile;M2-Moderate: Method 2 subgroup with a
Moderate profile; M2-Pathological : Method 2 subgroup with a Pathological profile; M2-Somatic:
Method 2 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a Depressed profile;
M3-Pathological : Method 3 subgroup with a Pathological profile.

Characterization of Pain Clusters based on all MMPI Variables
MMPI-2-RF Variables. MANOVA demonstrated overall group differences in the MMPI-2RF [Wilk’s Lambda; F(15, 434)=22230.3, p<.001, Eta2=1.00]. Subsequent ANOVA and
Tukey’s b post hoc analyses demonstrated significant differences between the groups in all the
MMPI-2-RF variables. Table 25 presents scale means and standard deviations for each group.
Figure 11 illustrates the subgroup mean profiles.
Table 25 and Figure 11 show that Method 3-3A subgroup only had high mean scores on
RC1 (this group will be referred Method 3-Somatic). The Method 3-3B subgroup had one mean
scores in the may be exaggerated range on FBS-r, and three high mean scores on RCd, RC1 and
RC2 (this subgroup will be referred as Method 3- Depressed). Finally, Method 3--3B subgroup
had one scale in the may be exaggerated range on Fp-r, three scores in the may be invalid range
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on F-r, Fs and FBS-r, four high mean scores on RCd, RC2, RC7 and RC8, and two scales with
very high mean scores on RC1 and RC6 (this group will be referred as M3-Pathological).
Table 25
Method 3 MMPI-2-RF mean, standard deviations, and statistical differences by pain subgroup

L-r
F-r
Fp-r
Fs
FBS-r
K-r
RCd
RC1
RC2
RC3
RC4

M3Somatic
65.0 (12.9)a
59.7(8.5)a
48.8(7.8)a
53.6(10.4)a
66.3(10.4)a
54.3(8.2)a
51.1(7.8)a
67.3(7.3)a
58.5(9.8)a
47.2(10.7)a
45.1(8.8)a

M3Depressed
60.8(11.0)b
80.2(11.3)b
56.8(11.0)b
70.6(15.6)b
80.6(12.7)b
41.9(8.3)b
67.0(7.3)b
78.5(9.2)b
69.8(11.8)b
53.9(10.8)b
51.5(10.6)b

M3Pathological
59.0 (11.4)b
112.1(9.6)c
76.6(17.7)c
90.9(16.9)c
91.4(11.3)c
36.3(6.8)c
77.4(6.0)c
88.6(8.7)c
76.8(12.6)c
62.7(11.4)c
56.7(11.8)c

F
9.6
935.1
176.3
221.2
160.5
193.5
475.4
214.1
89.4
67.8
41.7

p<
.001
.001
.001
.001
.001
.001
.001
.001
.001
.001
.001

Eta2
0.04
0.81
0.44
0.50
0.42
0.46
0.68
0.49
0.29
0.23
0.16

RC6

49.2(8.9)a

58.5(10.5)b

80.2(15.6)c

244.5

.001

0.52

RC7
RC8

a

43.4(6.7)
46.6(7.7)a

57.9(8.9)
57.1(8.7)b

72.9(9.4)
76.3(11.5)c

415.7
351.8

.001
.001

0.65
0.61

RC9

39.4(6.9)a

46.3(9.9)b

52.2(9.5)c

69.9

.001

0.24

b

c

Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile . F-r: Infrequency
restructured; Fp-r: Infrequency psychopathology restructured; Fs: Infrequency somatic symptoms; FBS-r:
Symptom Validity scale restructured; L: Lie restructured; K: Correction restructured; scales RCd-RC9:
RCd: Demoralization; RC1: Somatic Complains; RC2: Low Positive Emotions; RC3: Cynism; RC4:
Antisocial Behavior; RC6: Ideas of Persecution;RC7: Dysfunctional Negative Emotions; RC8: Aberrant
Experiences; RC9: Hypomanic Activation.
abc
row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test.
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Figure 11. Illustration of the profiles of the three subgroups described by the MMPI-2RF scales.

Note. M3-Somatic: Method 3 subgroup with a Somatic profile; M3-Depressed: Method 3 subgroup with a
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile . F-r: Infrequency
restructured; Fp-r: Infrequency psychopathology restructured; Fs: Infrequency somatic symptoms; FBS-r:
Symptom Validity scale restructured; L: Lie restructured; K: Correction restructured; scales RCd-RC9:
RCd: Demoralization; RC1: Somatic Complains; RC2: Low Positive Emotions; RC3: Cynism; RC4:
Antisocial Behavior; RC6: Ideas of Persecution;RC7: Dysfunctional Negative Emotions; RC8: Aberrant
Experiences; RC9: Hypomanic Activation.

As can be seen in Table 26, the Method 3-Pathological also had significantly more
patients scoring at the may be exaggerated and maybe invalid ranges than the Method 3Depressed; and the Method 3-Depressed in turn had more patients in the same ranges than the
Method 3-Somatic. Interestingly, the Method 3-Pathological had 91% of patients in the F-r may
be invalid range, compared to 5% of Method 3-Depressed and 0% of Method 3-Somatic. In the
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under-reporting scales L-r and K-r, Method 3-Somatic had slightly higher number of subjects
with elevations than the other groups. Differences between the groups were identified in all RC
scales at both elevation levels. While 66% of patients in Method 3-Somatic scored high on RC1,
the Method 3-Depressed and Method 3-Pathological had more than 95% of patients with high
mean scores on scales RC1. The Method 3-Pathological and the Method 3-Depressed differences
can be seen at higher RC1scores where the Method 3-Pathological had 85% patients with very
high mean scores while the Method 3-Depressed had 44%. The most noticeable differences
between the groups in the RC scales were in RC6, RC7 and RC8, where the Method 3-Somatic
had less than 8%, the Method 3-Depressed has about 25% and the Method 3-Pathological has
more than 81% of patients with high mean scores.
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Table 26
Method 3 percentage of Cases that fall above the selected cutoff per MMPI-RF variable

Scale
F-r
Fp-r
Fs
FBS-r
L-r
K-r

RCd
RC1
RC2
RC3
RC4
RC6
RC7
RC8
RC9

May be exaggerated
M3M3Depressed Pathological
16
95
11
54
31
72
62
88
24
18
0
0
High scores
M3M3M3Somatic Depressed Pathological
4
64
97
69
95
99
32
72
83
11
23
56
4
14
29
8
32
86
0
24
81
1
19
84
0
6
9
M3Somatic
0
2
2
14
38
11

M3Somatic
0
0
1
1
18
0
M3Somatic
0
6
2
0
0
1
0
0
0

May be invalid
M3M3Depressed
Pathological
5
91
0
12
15
59
22
52
6
5
0
0
Very high scores
M3M3Depressed
Pathological
3
47
44
85
24
49
0
4
1
2
3
52
2
30
1
34
1
2

Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile . F-r: Infrequency
restructured; Fp-r: Infrequency psychopathology restructured; Fs: Infrequency somatic symptoms; FBS-r:
Symptom Validity scale restructured; L: Lie restructured; K: Correction restructured; scales RCd-RC9:
RCd: Demoralization; RC1: Somatic Complains; RC2: Low Positive Emotions; RC3: Cynicism; RC4:
Antisocial Behavior; RC6: Ideas of Persecution;RC7: Dysfunctional Negative Emotions; RC8: Aberrant
Experiences; RC9: Hypomanic Activation.

MMPI-2 Variables. The three subgroups were also characterized using the all MMPI-2
scales. Once more, this was done to determine similarities and differences between the two
MMPI versions, but this time assessing MMPI-2-RF method to determine the subgroups.
MANOVA demonstrated overall differences in MMPI-2 mean scores between the three groups
[Wilk’s Lambda; F(16, 430) = 8320.8, p<.001, Eta2=1.0). Subsequent ANOVA and Tukey’s b
post hoc analyses demonstrated that there are significant differences between the three groups in
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all the MMPI-2 variables. Table 27 presents scales mean and standard deviations for each group.
Figure 11 illustrates the three subgroup mean profiles based on the MMPI-2 variables.
Table 27 and Figure 12 show that Method 3-Somatic had no elevated validity scales, one
scale with high mean scores (scale 2) and two scales with a very high mean score (scales 1 and
3) demonstrating a Triad profile. Method3-Depressed had one mean scores in the may be
exaggerated range (FBS), two high mean scores (scale 6 and 7), and four scales with very high
mean scores (scales 1, 2, 3 and 8) demonstrating a Moderate profile. Finally, Method 3Pathological had three scores in the may be invalid range (scale F, Fb and FBS), two high mean
scores (scales 4 and 0), and six scales with very high mean scores (scales 1, 2, 3,6, 7 and 8)
demonstrating a Pathological profile.
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Table 27
MMPI-2 scales means and standard deviations by Method 3 groups
M3M3M3Somatic
Moderate
Pathological
F
M(sd)
M(sd)
M(sd)
L
65.9(12.2)a
59.6(10.5)b
56.4 (10.1)c
27.1
a
b
c
F
52.1(7.0)
64.5(9.8)
89.7(16.4)
378.5
a
b
c
Fb
49.2(7.3)
69.7(14.2)
100.2(17.4)
484.4
a
b
c
Fp
50.8(10.4)
54.6(11.1)
67.8(16.9)
65.5
a
b
c
FBS
70.9(11.1)
84.5(14.2)
93.2(11.0)
112.4
a
b
c
K
58.8(8.7)
46.7(9.3)
38.7(6.6)
197.2
a
b
c
1
77.3(9.4)
82.8(10.4)
87.8(8.6)
40.2
a
b
c
2
73.7(11.4)
84.8(11.0)
90.0(9.2)
114.1
a
b
b
3
78.8(13.0)
86.7(16.8)
87.2(11.9)
15.4
a
b
c
49.4(8.4)
71.7(11.4)
58.0
4
57.0(9.5)
a
a
b
5
49.2(10.6)
49.4(8.4)
51.9(8.8)
3.7
a
b
c
6
51.7(10.1)
66.8(12.7)
88.6(14.4)
295.9
a
b
c
7
59.5(10.5)
74.4(10.7)
87.8(10.0)
247.9
a
b
c
8
61.0(8.7)
74.9(10.5)
96.3(10.6)
424.4
a
a
b
52.9(10.4)
60.1(11.3)
40.5
9
49.2(8.4)
a
b
c
0
50.2(8.1)
60.2(9.9)
70.9(8.9)
176.2

p<

Eta2

.001
.001
.001
.001
.001
.001
.001
.001
.001
.001
.025
.001
.001
.001
.001
.001

0.11
0.63
0.69
0.23
0.34
0.47
0.15
0.34
0.07
0.21
0.02
0.57
0.53
0.66
0.15
0.44

Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile . F: Infrequency; Fb:
Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom Validity scale; L: Lie; K:
Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4: Psychopathic Deviate; 5:
Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social
Introversion
abc
row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test.
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Figure 12. Illustration of the profiles of the three subgroups described by the MMPI-2
scales.

Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile . F: Infrequency; Fb:
Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom Validity scale; L: Lie; K:
Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4: Psychopathic Deviate; 5:
Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social
Introversion

As can be seen in Table 28, the Method 3-Pathological had significantly more patients
scoring at the may be exaggerated and maybe invalid ranges on all the validity scales than
Method 3-Somatic and Method 3-Depressed. The most noticeable difference between all
subgroups was on scale Fb where the Method 3-Pathological had 89% of patients scoring at may
be exaggerated range compared to 0% in the other two groups. Method 3-Somatic and Method 3Depressed had similar proportion of patients on scales F, Fb and Fp. On FBS, Method 391

Depressed had a higher proportion of patients than the Method 3-Somatic in the may be
exaggerated and may be invalid ranges. On the clinical scales, the most noticeable differences
were in scales 7 and 8 where the Method 3-Somatic had less than 10%, the Method 3-Depressed
had about 50% and the Method 3-Pathological had more than 90% of patients with very high
mean scores. The Method 3-Somatic, Method 3-Depressed and Method 3-Pathological had
similar number of patients with high mean scores on clinical scales 1, 2, and 3. However, Method
3-Depressed and Method 3-Pathological had more patients than the Method 3-Somatic with very
high mean scores on the same scales.
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Table 28
Method 3 percentage of Cases that fall above the selected cutoff per M1-Pathologicaly MMPI-2
variable
Maybe exaggerated
M3M3M3Somatic
Moderate
Pathological
Scale
F
Fb
Fp
FBS
L
K

1
0
2
26
39
-

1
2
3
4
5
6
7
8
9
0

M3Somatic
92
71
85
22
11
8
25
39
8
4

M3Somatic

30
91
0
89
4
21
67
94
18
11
High scores
M3M3Moderate
Pathological
96
99
94
99
89
96
50
73
2
9
57
97
85
99
84
100
15
34
31
79

0
0
1
1
13
22
M3Somatic
67
39
62
4
2
2
8
5
0
1

Maybe invalid
M3M3Moderate
Pathological
2
43
0
78
1
12
15
28
5
2
3
0
Very high scores
M3M3Moderate
Pathological
79
91
85
98
75
88
20
40
0
1
26
81
51
90
54
99
4
12
8
37

Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile . F: Infrequency; Fb:
Infrequency back; Fp: Infrequency psychopathology; FBS: Symptom Validity scale; L: Lie; K:
Correction; scales 1-0: 1: Hypochondriasis; 2: Depression; 3: Hysteria; 4: Psychopathic Deviate; 5:
Masculinity-Femininity; 6: Paranoia; 7 : Psychasthenia; 8: Schizophrenia; 9 : Hypomania; 0 : Social
Introversion

Non-MMPI Characteristics of Pain Clusters
Demographics . Differences between the three subgroups in demographic were tested using
ANOVA or Chi squared analysis where appropriate and Tukey’s post hoc analysis was
conducted when necessary. Table 29 presents demographic data by subgroup. There was a
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significant group effect for education and race with the Method 3-Somatic having higher
education and Method 3-Pathological having less percentage of Caucasians than the other
groups. Groups did not differ on any other demographic variables. Odd ratios analysis indicated
that the Method 3-Pathological subgroup was 2.6 (95% C.I. = 2.6-2.5) and 2.3 (95% C.I. = 2.32.2 ) less likely to be Caucasian than the Method 3-Somatic and Method 3-Depressed subgroups,
respectively.
Table 29
Method 3 Demographic characteristics by MMPI-2-RF based subgroups

Age
Education
Time since Injury
Gender (male)
Race (white)

M3Somatic
M(sd)
43.5(8.8)
12.3(2.5)a
35.6(28.7)
(%)
56.6
73.3a

M3Moderate
M(sd)
42.7 (9.0)
11.7 (2.5)b
41.5 (30.3)
(%)
67.8
70.6a

M3Pathological
M(sd)
43.1(8.2)
11.6 (2.6)b
40.1 (27.3)
(%)
64.8
51.6b

F
0.3
3.4
2.9
X2
4.4
19.2

p≤
NS
.034
NS
p≤
NS
.014

Eta2
0.00
0.02
0.01

Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile .
abc
row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test.

Injury Severity. ANOVA demonstrated that there were no differences in Injury Severity
mean scores between Method 3-Somatic (M = .82; sd = 1.1), Method 3-Depressed (M = .85; sd =
1.2), and Method 3-Pathological (M = .72; sd = 1.1) [F (1, 583) = 0.06, p > .05, Eta2=0.01].
Table 30 presents the injury and symptom characteristics of the sample as a function of group
membership. Differences between the three groups in injury/symptom characteristics were tested
using Chi squared analysis. As can be seen, groups did not differ in other injury type, location, or
etiology variable.
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Table 30
Percentage of patients with specific Injury/Symptom characteristics by pain group
M3M3M3Somatic
Moderate
Pathological
Primary back/spine injury
89.4
93.0
87.5
Head injury in accident
10.6
11.9
14.8
Other Pain symptoms / area of body
Head
28.2
40.8
31.0
Chest / abdomen
37.0
22.2
40.7
Upper extremity
40.1
31.9
28.0
Lower extremity
39.3
34.1
26.6
Spine Findings
any spine findings
39.2
35.3
25.5
degenerative disc/spine
36.1
36.1
27.8
herniated nucleus pulposus
32.0
44.0
24.0
disc bulge/protrusion
42.7
33.6
23.8
neural impingement
36.8
31.6
31.6
Spinal Surgery
discectomy / fusion
44.1
28.7
27.2
decompression/laminectomy
14.4
13.3
21.1
Other pain diagnoses
Complex regional pain syndrome
2.8
2.1
3.1
Fibromyalgia
1.7
3.5
2.3
Myofascial pain syndrome
5.0
1.4
5.5

X2
2.3
2.3

p<
NS
NS

1.4
2.4
0.1
2.9

NS
NS
NS
NS

2.7
1.4
1.9
2.2
0.1

NS
NS
NS
NS
NS

1.5
3.6

NS
NS

0.3
1.1
3.7

NS
NS
NS

Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile .
abc
row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test.

Legal Status. Table 31 presents the legal status of the sample as a function of group
membership. Differences between the three subgroups in legal characteristics were tested using
Chi squared analysis. Groups did not differ in the status of legal representation or referral source.
Groups differed in the type of legal claim. Method 3-Depressed had less patients claiming
workers compensation than Method 3-Somatic and Method 3-Pathological. Method 3-Somatic
and Method 3-Pathological did not differ on this variable. Odds ratio analysis indicated that the
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M3-Depressed was 1.4 (95% CI = 1.5-1.4) and 2.9 (95% CI = 3.1-2.8) less likely to be involved
in Workers Compensation than the Method 3-Somatic and Method 3-Pathological, respectively.
Table 31
Method 3 medico-legal characteristics of the chronic pain sample as a function of Cluster
membership.

Status of legal representation
No Attorney
Represented by attorney
Attorney status unknown
Referral source
doctor
case manager / adjuster
attorney
district attorney
Claim type
workers compensation
personal injury
disability

M3Somatic
%

M3Moderate
%

M3Pathological
%

26.1
61.1
12.8

36.4
51.7
11.9

23.3
45.0
4.4
26.1

X2

p=

31.3
55.5
13.3

4.1

NS

23.1
52.4
2.8
21.0

33.6
49.2
5.5
11.7

14.9

NS

82.5ab
17.5

76.7 b
21.7

90.6 a
9.4

16.3

.04

0.0

1.1

0.0

Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup with a
Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile .
abc
row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test.

Malingering Diagnosis. Table 32 presents the malingering diagnosis of the sample as a
function of group membership. The three subgroups differed significantly in the status of the
malingering diagnosis in MPRD [X2(4,583) = 135.3, p< .001]. More than half (59-71%) of
patients in the Method 3-Pathological were formally diagnosed as malingering compared to 3743 % patients in the Method 3-Depressed and 18-20% of Method 3-Somatic patients.
Odd ratios analysis indicated that the Method 3-Pathological was 34.7 times (95% C.I. =
34.9-34.5) more likely to be MPRD than Method 3-Somatic subgroup when not using the MMPI
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variables as malingering indicators. Similarly, Method 3-Pathological was 9.4 times (95% C.I. =
9.7-9.2) more likely to be MPRD than Method 3-Depressed subgroup when not using the MMPI
variables as malingering indicators. The Method 3-Depressed was 3.7 times (95% C.I. = 3.8-3.6)
more likely to be MPRD than Method 3-Somatic subgroup when not using the MMPI variables
as malingering indicators. When the MMPI variables were used as indicators the odd ratio to be
MPRD increased to 132.1 (95% C.I. = 133.1-131.4) for the Method 3-Pathological to the
Method 3-Somatic, to 18.2 (95% C.I. = 19.3-17.1) for Method 3-Pathological to Method 3Depressed. The likelihood to be MPRD for the Method 3-Depressed increased to 7.3 (95% C.I. =
7.4-7.1) when compared to the M3-Somatic.

Table 32
Method 3 malingering status by pain group
Method 3 MPRDa status by subgroup
M3M3Somatic
Depressed
%
%
a
56.0
28.3b
Not MPRD
24.5
34.4
Possible MPRD
14.7
30.0
Probable MPRD
4.9
7.2
Definite MPRD
19.6
37.2
All MPRD
Method 3 MPRDb status by subgroup
M3M3Somatic
Depressed
%
%
a
b
12.8
49.7
Not MPRD
28.7
42.8
Possible MPRD
16.8
37.2
Probable MPRD
4.9
7.2
Definite MPRD
18.3
42.7
All MPRD

M3Pathological
%
7.0c
33.6
45.3
14.1
59.4
M3Pathological
%
0.0c
28.9
57.0
14.1
71.1

X2

p<

85.0

.001

X2

p<

135.3

.001

Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup
with a Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile .
MPRDa: Malingered Pain Related Disability not including the MMPI-2 variables
MMPIb: Malingered Pain Related Disability including the MMPI-2 variables
abc
row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test.
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Pain Report and Outcome. To determine differences in report of pain and outcome, levels of
current pain, best pain and worst pain, as well as catastrophization and functional capacity were
compared among the three subgroups. Pain report was available for all patients. PCS scores were
available for 56 Method 3-Somatic patients, 42 Method 3-Depressed participants and 43 Method
3-Pathological participants. PDI data was available for 68 Method 3-Somatic participants, 88
Method 3-Depressed participants and 58 Method 3-Pathological participants. Table 33 presents
data for these variables by group. There was a significant group effect for “current” pain rating
with Method 3-Somatic reporting less subjective least amount of pain than the Method 3Pathological. The Method 3-Depressed did not differ from the Method 3-Somatic or the Method
3-Pathological in current pain ratings. Moreover, results showed that those in Method 3Pathological had significantly higher mean scores than Method 3-Depressed, and Method 3Depressed had significantly higher mean scores than Method 3-Somatic on the PC and PDI
scales.
Table 33
PCS and PDI scores as a function of pain group

Current Pain
Best Pain
Worst Pain
PCS
PDI

M3Somatic
M(sd)
6.2(2.0)
4.6 (2.1)a
9.3(1.5)
63.6(14.4)a
48.8(12.7)a

M3Depressed
M(sd)
6.5(1.9)
4.7(2.2)ab
9.3(1.0)
76.5(13.4)b
50.3(12.7)b

M3Pathological
M(sd)
6.8 (1.9)
5.3(2.3)b
9.2(1.5)
83.8(10.1)c
57.2(9.0)c

F
2.0
2.7
0.2
24.3
8.7

p≤
NS
.04
NS
.001
.001

Eta2
0.01
0.02
0.00
0.28
0.08

Note. Note. M3-Somatic: Method 3 subgroup with a Somatic profile;M3-Depressed: Method 3 subgroup
with a Depressed profile; M3-Pathological : Method 3 subgroup with a Pathological profile .
abc
row means with the same letter are not significant at alpha < .05 using Tukey’s b post-hoc test.
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Method 3 Summary and Conclusions
An exploratory two steps cluster analysis was conducted using the MMPI-2 scales F-r,
Fp-r, Fs, FBS-r, L-r and K-r and the nine RC scales. As Method 2, two and three cluster
solutions were determined to be appropriate solutions for the current sample. The three cluster
solution was selected to be further described because it provides valuable information over the
two-cluster solution. The three cluster solution was characterized by three homogeneous groups
that differed drastically in the number and type of MMPI-2-RF scales elevated as well as the
number of patients with elevation. Note that Method 3 classification agreed with Method 2
classification for about 75% of the cases demonstrating that there was an important overlap in
how the MMPI-2-RF and the MMPI-2 variables classify participants into subgroups.
The first subgroup was called Method 3-Somatic because it showed elevations only on
RC1 and did not show over-reporting of symptoms. The second subgroup was called Method 3Depressed because elevated on one validity scale (FBS-r) and on the deception, somatic
complains and depression scales (RCd, RC1 and RC2). Finally, the last subgroup was called
Method 3-Pathological because it was characterized by having elevations in all over-reporting
validity scales (i.e. F-r,Fp-r, Fs, FBS-r) and five out of the nine RC scales (i.e. RCd,
RC1,RC2,RC7, RC9).
The three groups also differed in all MMPI-2 scales, demonstrating the relationship
between the MMPI-2- RF scales and its original counterpart. However, like Method 2, some
MMPI-2-RF scales (i.e. RC3, RC4 and RC6) were less likely to be elevated by the pain
subgroups than the MMPI-2 counterparts. The three groups were also different in the Non-MMPI
variables: level of education, race, and malingering diagnosis. The Method 3-Somatic was
described as a highly educated group, which had the lowest number of patients diagnosed as
malingerers. The Method 3-Depressed was described as a low educated group, with the highest
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proportion of patients with personal injury claims and were 4 times more likely to be diagnosed
malingerers than Method 3-Somatic. Finally, Method 3-Pathological was described was less
educated and diverse than the Method 3-Somatic and it was the subgroup with the lowest number
of Caucasians. Finally, the Method 3-Pathological was 35 and 9 times more likely to be
diagnosed as malingering than the Method 3-Somatic and Method 3-Depressed respectively,
when the MMPI variables were not used as malingering indicators. The likelihood increased
significantly when the MMPI variables were used as indicators. In terms of outcome, Method 3Pathological also demonstrated the highest level of catastrophization and perceived disabilities
followed by the Method 3-Depressed and then the Method 3-Somatic. Thus, the results again
supported the previously found dose response relationship between subgroup profile elevations
and malingering and outcome report.
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CHAPTER VI
DISCUSSION
The general purposes of this study were 1) to establish through cluster analysis subgroups
and profiles from a large pain patient population evaluated in medico-legal settings using the
MMPI-2 and MMPI-2-RF; 2) to determine the relationship between subgroup membership and
selected non-MMPI variables, including pain perception and perceived outcome. Exploratory
two-step cluster analyses were conducted to group the participants using three different methods.
Method 1 used the MMPI-2 standard clinical scales and the traditional validity scales L, F and K
to test whether the previously found pain subgroups were also found in the present medico-legal
sample. Method 2 used all of the MMPI-2 scales to test whether the inclusion of all the available
scales impacted the number and the characteristics of pain subgroups. Finally, Method 3 used the
MMPI-2-RF scales to test whether a cluster analysis using these newly developed scales
influenced the previously found MMPI-2 cluster number and characteristics.
Method 1
Result demonstrated that the best natural “fit” for the current sample was the two-cluster
solution when Method 1 was used. The subgroups presented a Triad (high elevations on scales 1,
2, and 3) and a Pathological (extremely high elevations on multiple validity and almost all
clinical scales) profiles. These results are relatively similar to previous cluster analytic
investigations (i.e. Riley et al., 1993, Block & Ohnmeiss, 2000; Marters et al., 2002), which used
the same method to cluster pain patients. The only exception is that the current investigation did
not find a subgroup described by no clinical scale elevations (Normal).
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Method 2
When Method 2 was used, the most comprehensive solution was the three-cluster
solution. This solution found that in addition to a Triad and Pathological subgroups, there was a
Moderate subgroup. The Moderate subgroup was formed by 49% of patients originally classified
as Triad using Method 1, and 51% of patients classified as Pathological using Method 1. The
Moderate subgroup scored in the exaggeration range on FBS and had elevations on most clinical
scales; though these were not as extreme as the Pathological profile. With the appearance of this
Moderate subgroup, the Method 2 Triad and Pathological subgroups had more extreme scores
compared to the Method 1 subgroup counterpart. That is, the Triad subgroup scores were lower
and the Pathological subgroup scores were higher on all scales compared to their Method 1
counterparts.
Method 3
Finally, using Method 3 the most comprehensive solution was the three-cluster solution,
which described a Somatic, Depressed, and Pathological profiles. These subgroups were
described based on their RC elevations (see Tallegen et al., 2003 for more information). The
Somatic profile was defined based on elevations on scales that resemble somatization (RC1); the
Depressed profile was defined based on elevations on scales that resembles demoralization,
negative mood and somatization (RCd, RC1 and RC2); and the Pathological profile was defined
based on its multiple clinical elevations (Tallegen et al., 2003). When compared to Method 2,
85% of Somatic patients were also classified as Triad; 77% of Depressed patients were in the
Moderate subgroup; and 88% of Pathological patients were classified as Pathological in Method
2. Thus, MMPI-2-RF subgroups were composed, for the most part, of the same patients that were
identified in their Method 2 counterpart.
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MMPI-2 vs. MMPI-2-RF
Interestingly, the MMPI-2-RF subgroups resembled the MMPI-2 profiles when these
were described in terms of the MMPI-2 variables. That is, the Somatic group resembled an
MMPI-2 Triad profile; the Depressed subgroup resembled the MMPI-2 Moderate profile, and
the Pathological subgroup was similar to the MMPI-2 Pathological profile. However, there are
some differences between the test versions that are worth noting. For all profiles, there was an
apparent lack of relationship observed between scale 3 and its RC counterpart (RC3). One
explanation is that many somatic components of scale 3 are now represented in RC1 and not
RC3 (Tallegen et al., 2003). In fact, in three different community and psychiatric samples,
correlations between scale 3 and RC1 ranged from .60 to .70 while correlations between scale 3
and RC3 only ranged from .01 to -.20 (Tallegen et al., 2003).
The other most identifiable difference was that the Moderate subgroup elevated on
scales 4,6, 7 and 8 but did not elevate on their RC counterparts. These differences may be
because, like scale 3, items related to somatization on clinical scales 4, 6, 7 and 8 are now part of
RC1. This may demonstrate an ability of the MMPI-2-RF to capture the main components of
somatization on one scale. Similarly, items related to the component “demoralization” were
removed from these scales and located in RCd (Tallegen et al., 2003). According to Tallegen et
al (2008) demoralization was an important component of all clinical scales, so for the RC scales
these items were removed from the individual scales and combined to form the new RCd scale,
suggesting that RCd captures a core element of people with psychopathology. Thus the fact that
RCd was elevated by the Moderate subgroup when this was profiled by the MMPI-2-RF may
demonstrate that an important characteristic of this profile is demoralization.
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Interpretation of Profiles
Triad/Somatic Profile
The Triad or Somatic configurations are classically associated with somatization (for
review see Graham, 2006, Deardorff, 2000, Robinson, 2000; Tallegen et al., 2003). Patients with
this profile are vulnerable to developing physical symptoms in response to stress. They seek
medical explanations for their problems and lack insight into the psychological factors that may
underlie or influence the problems (Graham, 2006). Individuals with this profile may also
manifest depression as episodes of tension, distress, and complaints about weakness and fatigue
(Friedman et al., 2001). Somatization is also classically associated with medically unexplained
symptoms, poorer response to treatment, and future development of disability (Graham, 2006).
Therefore, in general, pain patients with Triad/Somatic profiles have maladaptive trait or coping
styles that in the present subgroups may be responsible for the limited recovery seen at least six
months after the injury.
It is important to note that the present investigation does not differentiate between the
Triad and the previously reported conversion V profiles differentiated by Graham(2006).
Although scales 1 and 3 were higher than scale 2 in the current study (see Figure 5), which
defines the conversion V profile, these were in the same descriptive range (i.e. Very High
scores). As discussed by several authors, the major difference between the Triad profile and the
conversion V profile is that the first may represent patients who are experiencing depression
secondary to adjustment to significant pain symptomology (Graham, 2006). However, this
differentiation has to be used with caution because as Keller and Butcher (1991) suggested,
while somatizizers consistently endorse items reflecting somatic distress, they may be more
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variably endorsing depressive items. Thus, regardless of how they are labeled, the main
psychological problem of this subgroup is somatization.
Moderate/Depressed Profiles
The interpretation of the Moderate/Depressed profiles is more difficult than the
Triad/Somatic profile because these had not been identified by previous investigations.
Moderate/Depressed profiles should certainly be associated with higher levels of psychological
overlay than the somatic subgroups because they report high elevations in more number of scales
including scales that measure depression, anxiety, and demoralization, among others. However,
these profiles are also characterized by elevations on FBS/FBS-r suggesting that these patients
also exaggerate some symptoms. Elevations on FBS suggest that there is exaggeration of
physical and cognitive symptoms; a type of exaggeration that is not captured by the other overreporting scales. As mentioned by Lees-Haley et al. (1991) FBS was created to detect
exaggeration of somatic and/or non-psychotic symptoms whereas the other over-reporting scales
(F,Fb and Fp) collectively termed F family, may be more sensitive to rare psychotic or other
rarely endorsed psychological symptoms. Exaggeration of symptoms is supported by the
important number of known malingerers that were classified in the Moderate/Depressed (~
35%), suggesting that a significant number of these patients also purposefully underperformed
and/or exaggerated symptoms on other psychological measures. Therefore, patients with
Moderate/Depressed configurations may have important and diverse psychological problems and
exaggerated non-psychotic symptoms.
Pathological Profiles
Several studies have interpreted Pathological profiles (e.g., Riley, 1995; Block &
Ohmeiss, 2004, Gatchel et al., 2006). Research has shown that patients with this profile suffer
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from severe psychopathologies (Costello, 1997). These investigations have suggested that their
very high scores demonstrate severe pre-morbid psychological issues (Graham, 2006) and fewer
resources to cope with physical symptoms compared to those with Normal or Triad profiles
(Riley, 1995). In a recent study, subjects with Pathological profiles were six times more likely to
have an Axis 1 clinical disorder (such as major depressive or anxiety disorders) and three times
more likely to have an Axis II personality disorder compared to those with Triad profiles
(Gatchel, et al., 2006).
However, and perhaps more importantly, the present Pathological subgroup also
demonstrated elevations on all of the over-reporting validity scales, a finding that was not
described or discussed by previous investigators. These elevations demonstrate that patients with
Pathological profile exaggerate a multiple array of symptoms. In fact, the majority of these
patients were known malingerers (~ 65%), indicating that patients with Pathological profiles are
likely intentionally exaggerating these symptoms. Thus, significant concerns regarding validity
of the report should be raised when patients present Pathological profiles in medico-legal pain
evaluations.
Summary
The two-cluster solution was considered the best solution when it was used the traditional
method (Method 1). However, the three-cluster solution was considered the most comprehensive
in the methods that used the most complete set of scales (i.e. Method 2 and Method 3). Thus, the
three-cluster solution is considered the most adequate solution when using the MMPI-2 or
MMPI-2-RF to differentiate patients with financial compensation seen in medico-legal settings.
There was significant patient overlap between the MMPI-2 and the MMPI-2-RF
subgroups/clusters. However, in general, the MMPI-2-RF seems to be simpler than its original
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counterpart in terms of capturing pain related problems by combining somatization into one scale
and by increasing scale distinctiveness when removing demoralization. Yet, much research is
needed in this area in order to determine if because of this simplification important pain related
information is lost. In general, the MMPI-2/MMPI-2-RF three-cluster solutions described a
Triad/Somatic, Moderate/Depressed and Pathological profiles. Subjects with Triad/Somatic
profiles are shown to have a tendency to express psychological problems or stress in physical
symptoms and complains. Patients with Moderate/Depressed profiles are expected to have more
diverse and moderate psychological problems that may be related to exaggeration of nonpsychotic symptoms. Finally, those with Pathological profiles have diverse and severe
psychological problems that are due, for the most part, to malingering.
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CHAPTER VII
Factors Related to Subgroup Membership
Injury Severity
For each method, differences between the resulting subgroups were compared on several
important variables. Results showed that subgroup membership was not conditioned to any
spine- related organic factor. Thus, differences in MMPI reporting were not due to organic
changes consistent with several investigations (e.g. Schade, Semmer, Main, Hora, & Boos,
1999). Instead, elevated profiles were related to malingering status and a variety of other sociodemographic variables, including low education, ethnic diversity and legal status. The following
sections provide some discussion about the relationship between group membership and these
external variables.
Malingering Status
This study demonstrated an exponential increase in the number of malingerers with
profile elevations. That is, the number of malingerers increased from 15% in the Triad/Somatic
to 30% in the Moderate/Depressed subgroups and to 65% in the Pathological subgroups. Odd
ratio analysis also indicated that if a patient has a Pathological profile he/she is about 30 times
more likely to be malingering than a patient with Triad/Somatic profile; and about 7 times more
likely than a patient with a Moderate/Depressed profile. Similarly, a patient with
Moderate/Depressed profiles is about 3.5 times more likely to be malingering than a patient that
presents a Triad/Somatic profile. Thus, the more elevated the MMPI profile the greater should be
the concern regarding the motivation of the individual to report their symptoms.
This dose response relationship also supported two fundamental assumptions in
malingering research. First, that methods to assess psychological abilities and problems are
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vulnerable to intentional exaggeration (Bush et al., 2005).Second, the more inconsistencies a
patient presents across multiple or relatively independent domains (i.e. cognitive, physical,
emotional), the more likely it is that his/her performance reflects deliberate efforts to
misrepresent their symptoms on a self-report measure (Bianchini et al., 2005; Larrabee,
Greiffenstein, Greve, & Bianchini, 2007).
In addition, it is important to note that physical findings, symptom report or type/number
of surgeries were not related to invalid symptom presentation on the MMPI, and thus
malingering status. This supported the assertions that persons with confirmed spine pathology
can and sometimes do malinger (Bianchini and Greve, 2009) and constrated the view of Bogduk
(2004) which indicated that a diagnosis of malingering “can be refuted if a genuine source of
pain can be established” (p. 409). These results are also consistent with Bianchini and Greve
(2009), which reported definite malingering in patients with objective physical findings who had,
in fact, had surgery. Thus, even willingness to undergo invasive procedures such as spinal
surgery should not rule out malingering (Bianchini, Curtis, & Greve, 2006).
Obviously, malingering was not caused by the physical injury which has become the
subject of the legal claim of these patients. However, malingering was shown to co-exist with
other psychosocial factors and these psychosocial factors can certainly exist in the absence of
malingering. The next sections explain these factors’ relation to elevated MMPI profiles and to
symptom exaggeration/malingering.
Education and Ethnicity
Analyzing the nature of the relationship between ethnicity and education with elevated
MMPI profiles (i.e. Moderate/Depressed and Pathological profiles) is complicated by a large
number of confounding variables. While it is certainly possible that there is a direct relationship
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between education and ethnicity on symptom report, it is also possible that other related
variables are indirectly involved. For instance, patient differences in pre-morbid cognitive and
emotional functions, stress regulation, as well as their financial needs- all variables that have
shown to be highly correlated with low education and ethnic diversity -are shown to play
significant role in the manifestation of symptoms and the ability to cope with difficulties (Guillen
et al., 2010; Kirmayer, Groleau, Looper & Dao, 2004). Thus, it is still not clear at this point
exactly how low education and ethnicity influence MMPI pain reporting.
Nevertheless, results from this and other investigations suggest that education and
ethnicity may be highly associated with exaggerated report of symptoms (e.g. Binder, Kelly,
Villanueva, & Winslow, 2003; Salazar, Lu, wen & Boone, 2007l; Victor & Boone, 2007)
although not necessarily with malingering (Salazar, Lu, wen & Boone, 2007; victor & Boone,
2007 ). One potential explanation is that persons with lower education and minorities may
employ less sophisticated exaggeration strategies, making them easier to distinguish from real
injury profiles (Franzen & Martin, 1996). Another explanation is that education and ethnicity are
highly linked to low socio-economic status which may increase the decision to exaggerate
symptoms. Socioeconomic status may affect the perception of a particular settlement or
disability payment, with low socio-economic status perceiving a higher relative gain (Tait,
Chibnall, Andresen & Hadler, 2006). Adding to this, sufferers with low economical resources
may view a settlement and/or disability payments as essential for basic support due to having
fewer alternatives such as post-injury employment (Boyer et al., 2009).
Non Work- Related Claims
Interestingly, results from this investigation suggested that Moderate/Depressive profiles
are linked to claims that are non-work (e.g., personal injury) related. Specifically, the
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Moderate/Depressed subgroups were 1.3 to 3.3 less likely to be involved in workers
compensation claims than the other subgroups. One reason for these results may be a positive
relationship between non-working legal status and symptom report (Rosomoff, 1995). A
potential explanation is that those with non-work claims are more likely to be sophisticated
malingerers (since malingering was not related to non-working claims). Patients in non-working
claims may have more law suit opportunities making them more familiar with malingering
indicators (Lanyon & Almer, 2002). Patients in non-work claims may also be more often
coached than those in working claims as they are more likely to have an active attorney present
on their case (Gunstad & Suhr, 2001). Reports have suggested that many validity scales are
vulnerable to familiarity and coaching (eg., Dunn, Shear, Howe & Ris, 2003; Gunstad & Suhr,
2001; Powell,Gfeller, Hendricks & Sharland, 2004; Rose,Hall, Szalda & Bach, 1998) including
reports that show that the “F family” scales do not differentiate those with real injuries from
those that are properly coached (Storm & Graham, 2000). This may explain why those with
Moderate/Depressed profiles do not elevate on the F family scales. However, neither coaching
nor number of litigations were assessed in this study, and thus, the actual relationship could not
be determined.
Outcome
Results from this investigation show that subgroup membership was an important
predictor of scores in current pain reports and outcome measures. Specifically, the Triad/Somatic
subgroups had the best scores in current pain, catastrophizing and perceived disability, the
Moderate/Depressed subgroups had worst outcome scores than the Triad/ Somatic profile, but
better than the Pathological subgroup, a subgroup that reported the highest scores on the
outcome measures. Consequently, it can be inferred that those with Triad/Somatic profiles would
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have best recovery from a spine injury followed by those with Moderate/Depressed and then the
Pathological profiles. These results are consistent with several other investigations (e.g. Block &
Ohnmeiss, 2000; den Boer, Oostendorp, Beems, Munneke, & Evers, 2006; Kidner, Gatchel, &
Mayer, 2010) that have demonstrated that MMPI-2 profile elevations are associated with
increasing pain perception, disability and with poorer outcome from traditional and unilateral
treatment interventions.
However, there are some important issues that need to be taken into consideration when
associating outcome to MMPI profile. First, while the Triad/Somatic profiles had best predictive
outcome scores in this study, this is not to say that patients with this profile had “good”
outcomes. In fact, previous investigations have shown that patients with Triad profiles have the
tendency to report high levels of catastrophizing , take long disability times (Asmundson, &
Carleton , 2009; Bigos et al., 1991; Vendrig & Lousberg,1997) and not recover properly from
surgery (Block, Gatchel, Deardorff, & Guyer, 2003) when compared to normal profiles. Second,
due to large exaggeration report and/or malingering in both the Moderate/Depressed and the
Pathological subgroups it is difficult to infer if outcome report is due to the injury or incentives.
Indeed, the magnitude of outcome is a central forensic issue in that how disabled or how
impaired a person is or claims to be dramatically affects the monetary value of his or her claim
(Bianchini et al., 2005). In this view, subjects are as or more likely to exaggerate their outcome
report as well as their pain or symptom complaints.
Summary
Subgroup membership was not conditioned to any spine related organic factor. Instead,
malingering status had a strong dose-response relationship with subgroup profile elevations
suggesting that the more elevated the MMPI profile the greater the chance that an individual is
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malingering. Education, ethnic background and legal status were also different among pain
subgroups. However, while these psychosocial factors can certainly influence symptom
perception in the absence of malingering, these may also increase the likelihood of symptom
exaggeration. Lastly, there was a dose-response relationship between perceived outcome and
MMPI subgroup profile elevation, suggesting that the more elevated MMPI-2 profile is the less
likely the patient is to recover properly from spine injuries.
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CHAPTER VIII
Implications
In this study, psychological factors and non- organic factors were responsible for
symptom report and, in turn, responsible for perceived outcome. This is consistent with the
abundance of scientific/empirical evidence demonstrating that psychological factors, and not
physical characteristics of spine injuries, explain the presence of pain symptoms or disability in
medico-legal chronic pain patients (Gatchel & Kishino, 2011; Saastamoinen, Laaksonen, LeinoArjas & Lahelma, 2009). As a result, failure to examine psychosocial issues in pain patients may
lead to inappropriate conclusions regarding causality and severity of symptoms, as well as ability
to return to work or recover from surgery (Gatchel et al., 2006; Gatchel & Kishino, 2011).
Moreover, this study demonstrated a strong relationship between malingering and
subgroup membership above and beyond physical findings/surgery. Since malingering can lead
to diverse and severe symptom complaints, it can largely affect decisions and conclusions
regarding the presence, nature, cause, treatment, and functional implications of pain-related
disability (Aronoff et al., 2007). As a result, before any questions regarding pain- related
disability can be addressed, the information obtained from a psychological assessment of validity
/ malingering must be rigorously examined. As stated in a recent position paper from the
National Academy of Neuropsychology, “Adequate assessment of response validity is essential
in order to maximize confidence in the results of neurocognitive and personality measures and in
the diagnoses and recommendations that are based on the results” (Bush et al., 2005, p. 419).
Results from this study further support the importance of pre-surgical/procedure
psychological screenings. Block et al. (2003) have argued that pre-surgical psychological
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screening is an essential component in the medical diagnostic process of spine surgery
candidates, especially when the major goal is pain reduction and improved functionality.
However, it is also important that psychological pre-surgical/procedure screenings take into
consideration the psychosocial factors related to high- risk profiles in this study (i.e. education,
ethnicity, legal status, malingering). A psychological pre-surgical/procedure screening that
considers these factors may be able to answer the questions related to not only whether a certain
case is likely to have a poor outcome but also whether psychosocial problem(s) influence the
compensable injury and whether those factors contribute in a meaningful way to the patient’s
alleged disability.
Similarly, the present study may be used as a guide in active pain management programs
after malingering has been ruled out. That is, by identifying those patients with high risk profiles,
conservative or functional interventions such as cognitive behavioral interventions may be
recommended as more adequate than relatively independent physical treatments (Gatchel &
Okifuli, 2006).
Limitations and Future Studies
There are some limitations to this investigation. One limitation is that the current sample
may not be representative of all spine pain patients. This sample was composed of patients with
chronic pain (patients that have not recovered six months after the injury), a type of pain episode
that has been linked to emotional distress (Turk & Melzack, 2003). This explains why this study
did not find a profile with no psychological overlay or Normal profile. Although another
possibility for not finding this profile might be that all those with monetary compensation have
elevated MMPI profiles (Rohling, Binder & Langhinrichsen-Rohling, 1995; Meyers et al., 2002).
Therefore, in order to better clarify the role of spine injury on symptom report, future cluster
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analysis investigation should also include medico-legal patients with acute or recurrent pain
episodes.
Another limitation is that the current study only used self-report measures of outcome,
instead of practical measures of outcome such as length of return to work or surgery recovery.
Future studies may increase the predictive validity of the current findings by evaluating these
practical outcome variables in patients that present the above profiles. Future studies could also
identify how low-socioeconomic and legal statuses influence MMPI pain symptom and
malingering report – specifically, how non-malingering spine patients with different
socioeconomic and legal statuses perform on psychological measures. Finally, it is important to
conduct similar cluster analytic studies on other psychological measures (i.e. Personality
Assessment Inventory, Millon Clinical Multiaxial Inventory) as they might provide further
insight on the emotional similarities/differences of spine pain subgroups.
CONCLUSION
This study expands on previous cluster analytic investigations by better describing the
physical, psychological, and socio-legal factors that influence MMPI-2 and MMPI-2-RF based
subgroups of spine pain patients. The present study also illustrates the clinical circumstances that
can influence a given patient (based on their MMPI profile) to recover from a spine injury,
specifically those patients that are seen in medico-legal contexts. As a result, the current study is
relevant for informing decisions regarding possible physical interventions including pre-surgical
screening and choosing between conservative and more invasive physical interventions.
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APPENDIXES
Appendix A: Common Physical Impairments that Cause Spine Pain
Muscle Ligament Injuries are relatively common consequences of strenuous physical
activity. Sprains are injuries involving ligaments. Sprains are usually caused by trauma that
displaces a joint resulting in stretching or tearing of the associated ligament(s).
In disc bulge and herniation, pain that may result directly from the annulus tears, from
irritation caused by the release of chemicals from the nucleus, or by compression of the nerve
root.
Myofascial pain syndrome refers to musculoskeletal pain arising from localized trigger
points in a rigid band of muscle. These focal trigger points are tender to palpation may cause
muscle weakness or reduced range of motion.
Radiculopathy /Sciatica refers to a disruption of (or near) the nerve root that can result in
pain as well as sensory or motor disturbances. An important feature of radiculopathy is that
symptoms are often referred to the limb associated with the disrupted nerve.
Spinal Stenosis refers to a narrowing of the spinal canal, nerve root canal, or foraminal
openings from which nerve roots exit the canal. Symptoms typically occur when these nerve
fibers become impinged.
Spondylolysis refers to a stress fracture of the pars interarticularis, the narrow bridge
between the upper and lower facet joint of a vertebrae. A condition known as spondylolisthesis
can occur if the fracture is bilateral and the vertebrae slip out of alignment. When pain is present
it is thought to be caused by nerve root compression, intervetebral disc pain, or facet joint pain.
Spondylosis is a condition caused by age-related disc degeneration that causes a number
of pathological processes that can ultimately result in a narrowing of the spinal canal.
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Whiplash-associated disorder (WAD) refers to a collection of symptoms resulting from
rapid hyperextension/flexion of the neck, often associated with motor vehicle accidents.
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Appendix B:The Pain Disability Index
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Appendix C: Pain Chatastrophizing Scale
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Appendix D: Malingering Classification Method
Determination of malingering status (i.e. MPRDa and MPRDb) was based on the criteria
proposed by Bianchini et al., (2005). Classification relied on performance on psychometric
indicators and examination of available records.
Psychometric indicators. The cutoffs for the indicators used for MPRD classification
were based on examination of classification accuracy data derived from published criteriongroups’ validation (known-groups) traumatic brain injury studies and in consideration of the
general literature on specific indicators. In all cases, the cutting scores were based on the
performance of patients seen for neuropsychological evaluation for claims of brain injury and the
samples included patients with objectively documented brain pathology.
Classification accuracy data for the psychometric indicators used in this study were
obtained from: 1) Test of Memory Malingering (TOMM, Tombaugh, 1996) data from Greve,
Bianchini, and Doane (2006); 2) Portland Digit Recognition Test (PDRT; Binder, 1993) data
from Greve and Bianchini (2006); 3) Word Memory Test (WMT; Green 2005; Green Allen &
Astner, 1996) data from Greve, Ord, Curtis, Bianchini, and Brennan (2008); 4) Reliable Digit
Span, Digit Span, Working Memory and Processing Speed Indexes from the Wechsler Adult
Intelligence Scale –III (WAIS-III; Wechsler, 1997) data from Etherton, Bianchini, Heinly, &
Greve (2006ab), Etherton, Bianchini, Ciota, Heinly, and Greve (2006), and Heinly et al., (2005)
; 5) Recognition Hits raw score data were from the California Verbal Learning Test (CVLT;
Delis, Kramer, Kaplan, & Ober, 1987, 2000) data of Curtis, Greve, Bianchini, and Brennan
(2006); 6) Millon Clinical Multiaxial Inventory-III (MCMI-III; Millon, 1994) data from
Aguerrevere, Greve, Bianchini and Ord (under review). 8) F, Fb, Fp and Symptom Validity

133

Scale (FBS; Lees-Haley, English, & Glenn, 1991) from the MMPI-2 TBI data of Greve,
Bianchini, Love, Brennan, and Heinly (2006). Regarding the CVLT, data showed that the
classification accuracy of Recognition Hits is equally accurate in CVLT-1 and CVLT-2 at the
selected cutoffs (Greve, Curtis, Bianchini, & Ord, 2009).
Selected Cutoffs. Table A presents the data on the classification accuracy of the selected
cutoffs for each indicator. Also reported in Table A is Positive Predictive Power (+PP) for the
weakest value that were considered positive for each variable and Negative Predictive Power (PP) for the weakest variable values that were considered negative. The predictive values were
derived using a hypothetical malingering baserate of 35% (based on Mittenberg, Patton,
Canyock, & Condit, 2002). +PP and -PP provide a concrete index of confidence that a patient is
malingering or not malingering, respectively. Application of this system results in each score
being classified as 1) a negative indication of response bias or malingering; 2) an ambiguous
indication of response bias or malingering; or, 3) a positive indication of response bias or
malingering.
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Table A
Cutoffs and Malingering Indicators for MPRDa and MPRDb
Indicator
Negative
-PP
Ambiguous
Positive
Test of Memory Malingering
Trial 2
50-49
.82
48-45
44-0
Retention
50-49
.83
48-45
44-0
Portland Digit Recognition Test
36-28
.86
27-23
22-0
Easy
Hard
36-23
.86
22-18
17-0
Total
72-50
.88
49-45
44-0
Word Memory Test
IR
100-80
.83
78.5-72.5*
70-0
100-80
.83
78.5-72.5*
70-0
DR
CNS1
100-75
.83
72.5-57.5*
55-0
Wechsler Adult Intelligence Scale
RDS
17-8
.87
7
6-0
DS
30-8
.85
7-5
4-0
WMI
155-81
.88
80-76
75-45
PSI
155-76
.84
75-71
70-45
California Verbal Learning Test
Rec Hits
16-12
.82
11-10
9-0
Millon Multiaxial Clinical Inventory-III
Disclosure
0-55
.85
56-70
71-115
Debasement
0-65
.86
66-70
71-115
115-60
.77
59-55
54-0
Desirability
b
Minnesota Multiphasic Personality Inventory-II (only for MPRD )
F
0-65
.82
66-80
81-130
Fb
0-65
.80
66-85
81-130
Fp
0-65
.73
66-80
81-130
0-24
.84
24-28
29-32
FBS(raw)

+PP
.85
.91
.97
.93
.95
.86
.85
.88
.84
1.00
.86
.89
.91
.84
.88
.87

*The WMT scores are recorded in increments of 2.5% so scores between 80 and 78.5 and
between 72.5 and 70 are not possible.
-PP = Negative Predictive Power, the minimum probability that a negative score was
produced by a non-malingering case assuming a malingering baserate of .35; +PP = Positive
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Predictive Power, the minimum probability that a positive score was produced by a .malingering
case assuming a malingering baserate of .35; CN1 = consistency of recall between IR and DR
from the Word Memory Test; DR = delayed recall trial from the Word Memory Test; DS = Digit
Span scales score; IR = immediate recall trial from the Word Memory Test; PSI = Processing
Speed Index; Rec Hits = Recognition Hits from the California Verbal Learning Test; WMI =
Working Memory Index.
Significantly Below Chance Performance. A statistically significantly below-chance result on
a forced-choice SVT is definitive evidence of intentional exaggeration of cognitive deficits
(Bianchini et al., 2001; Frederick & Speed, 2007; Reynolds, 1998). This has been recognized in
both published systems for diagnosing malingering (Bianchini et al., 2005; Slick, Sherman, &
Iverson, 1999). A below chance result “is not a random or chance occurrence but represents a
purposive distortion by the examinee” (Reynolds, 1998; p. 272; emphasis added). In this study,
below chance results were possible on the PDRT, TOMM and/or WMT. For the TOMM, two
tests a score of 17/50 or less was considered significantly below chance (below the lower bound
of the 95% confidence interval around a score of 25/50). For the PDRT, scores of 11/36 on Easy
and Hard, and 27/72 on Total were considered significantly below chance. For the WMT, below
chance was 13/40 on Immediate and Delayed Recognition.
Qualitative Inconsistencies. Four kinds of inconsistencies were considered as part of the
MPRD classification: 1) non-organic or functional findings on physical examination (exclusive
of Functional Capacity Evaluation [FCE]); 2) an inconsistency between the patient’s behavior
during examination and their behavior when they do not believe they are being observed; 3)
inconsistencies between the patient’s subjective report of symptoms or history and their
documented history; and, 4) evidence of submaximal effort, symptom magnification, or non-
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organic / function findings on a formal FCE. Multiple inconsistencies are required to contribute
to a diagnosis of MPRD to account for their qualitative nature.
Operationalization of MPRD. The operationalization of the MPRD criteria results in a
given score being considered positive, negative, or indeterminate (neither clearly positive nor
negative). Moreover, because at least two qualitative inconsistencies are required to reach at least
the Possible designation, patients with only one inconsistency are not clearly classifiable. Thus,
the cases who do not meet criteria for an MPRD diagnosis were further divided into three
groups: 1) those with no positive psychometric findings or inconsistencies; 2) those with no more
than one ambiguous psychometric finding and no inconsistencies; 3) those with two or more
ambiguous psychometric findings and/or only one inconsistency. In summary, using the above
described system, patients were initially placed into one of the following six groups:1) negative
on all indicators used.2) a single ambiguous finding with no qualitative inconsistencies present
and otherwise negative.3) more than one ambiguous psychometric finding but no positive
psychometric findings or a single inconsistency.4) at least one positive psychometric finding or
one or more inconsistencies but did not meet full criteria for malingering.5) met criteria for
probable malingering.6) met criteria for definite malingering.
For purpose of this study, patients in groups 2 and 3 were combined into a single
Incentive-Only group. The group 4 cases were referred to as Indeterminate while groups 5, 6,
and 7, were called Possible, Probable, and Definite MPRD, respectively. See Table B
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Table B
Group
1
2

Initial Malingering Classification
negative on all indicators
only one ambiguous finding

3

more than one ambiguous finding but no positive findings

4

at least one positive finding but does not meet criteria for
malingering

5
6

meets criteria for Probable MPRD
meets criteria for Definite MPRD
Final Malingering Classification
Not Malingering (groups 1 and 2)
Indeterminate (group 3)
Possible MPRD (group 4)
Probable MPRD (group 5)
Definite MPRD (group 6)
All MPRD (groups 5 and 6)
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